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1. GENERAL INTRODUCTION 
1.1 Dissertation organization 
This dissertation begins with an introduction and a review of pertinent literature 
followed by three independent research papers that are to be submitted, and a conclusion. 
Each paper has a specific introduction, methods, results, discussion, and references. The 
literature review chapter is intended to provide a background on heart rate variability and 
heart rate signal analysis. References cited within the introduction and literature review 
sections are listed following the conclusion. 
1.2 Introduction 
Immediately after returning to Earth fi-om space, inadequate cardiovascular 
adjustments to a one-gravity environment are not only an annoyance to astronauts but can 
lead to flmctional incapacitation in the upright or standing position (Fritsch-Yelle et al., 
1996). This physiological phenomenon, called "orthostatic intolerance", is defined as the 
inability of cardiovascular responses to maintain the homeostatic state of the body, primarily 
typified by a sudden decrease in arterial pressure and cerebral blood flow, which causes 
syncope, in other words, fainting (Convertino, 1984). This is a recognized consequence of 
not only space flight but also prolonged standing and sudden standing from lengthened bed 
rest (Fritsch-Yelle et al., 1994; Goldberger et al., 1986). 
Upon returning to Earth from space, the increased gravitational force (from OG to IG) 
results in shifting blood to the lower body. Consequently, venous retxam, stroke voltune, 
cardiac output, arterial pressure, and the blood flow to cerebral regions decrease with 
developing orthostatic stress. Tolerance to orthostatic stress varies between individuals. 
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genders, and age groups (Hordinsky et al., 1981; Low et al., 1997). Many researchers have 
employed a tool called lower body negative pressure (LBNP) to generate orthostatic stress in 
humans (Blaber et al., 1995; Hughson et al., 1994; Lawler et al., 1998; Rowell et al., 1973; 
Zoller et al., 1972), thereby enabling controlled physiologic response studies of difFerent 
individuals subjected to similar orthostatic stress states. 
Females and the elderly present higher heart rates and increased susceptibility to 
presyncope when subjected to increased levels ofLBNP (El-Bedawi and Hainsworth, 1994; 
Hordinsky et al., 1981). However, these findings are not universal since several studies have 
indicated no orthostatic stress difference in tolerance between genders or even a higher 
tolerance in females than males (Hudson et al., 1987; Ramaekers et al., 1998). Although 
many researchers have demonstrated differences in tolerance to orthostatic stress between 
gender and age groups (El-Bedawi and Hainsworth, 1994: Lawler et al., 1998; Low et al., 
1997; Ramaekers et al., 1998), no researchers have quantified the gender difference in 
tolerance after controlling body size. In most of the previous research, the male groups were 
considerably taller and heavier than the female groups (Frey and Hoffler, 1988; White et al., 
1996; White and Montgomery, 1996). 
The extensive application of signal processing techniques to the medical field 
provides a variety of tools to enable understanding of the biological systems of the body. 
Analysis of the electrocardiogram, one of the unique and vital bioelectrical signals produced 
in the body, and of heart rate signal fluctuations are the two most commonly used methods 
for elucidation of the physiological and clinical condition of the heart. 
Due to the enormously cumbersome numerical procedures associated with analysis of 
variations of the heart rate signal, commonly referred to as "heart rate variability (HRV)", 
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the beat to beat variation in cardiovascular signals had received little attention until the 
advent of digital computers (Appel et al., 1989). However, advances in digital processing 
techniques and increase in data processing speed have facilitated steps such as feature 
recognition, statistical signal analysis, and modem time or frequency domain analysis. As a 
result, interest in HRV has increased dramatically over the past decade (Appel et al., 1989; 
Kitney and Rompebnan, 1980) with HRV now becoming the accepted tool for describing 
variations in consecutive cardiac cycles (Task Force, 1996). 
HRV is capable of reflecting the interplay between factors that perturb the 
cardiovascular system such as physical, psychological, and/or environmental stimuli (Appel 
et al., 1989; Kitney and Rompelman, 1980). Homeostatic adjustments to these perturbations 
are made primarily by autonomic modulation of the cardiac conduction system and the 
baroreceptor-evoked reflex responses of changes in heart rate, cardiac output, and peripheral 
vascular resistance. 
The early approach to HRV was to perform simple statistical analysis of heart rate 
data. However, since this method shows only the existence of changing physiological 
conditions, which is an unspecific characteristic, the analysis of HRV patterns has recently 
become of interest. Analysis of patterns and coherent features traced out by heart rate 
fluctuations offers the potential for providing detailed structural and behavioral information 
about underlying physiological mechanisms (Sayers, 1973). 
Power spectral density analysis methods have been adapted to analyze patterns of 
heart rate variations (Mathias et al., 1993; Pomeranz et al., 1985). Spectral analysis 
decomposes a signal to its frequency components and quantifies the strength of different 
frequency components (Lipsits et al., 1990). Spectral analysis provides a unique way to 
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interpret underlying patterns of neural control of the heart rate; the low frequency region of 
beat to beat interval spectra (0.04 to 0.15 Hz) reflects both parasympathetic and sympathetic 
neural activities while the high frequency region (0.15 to 0.4 Hz) reflects only 
parasympathetic activity. However, because of the non-deterministic characteristics of PIRV 
signal, full understanding and proper interpretation of HRV has not yet matured. 
In the last few years, wavelet analysis techniques have been considered as an 
alternative pattern analysis technique that more properly addresses the non-stationary nature 
of HRV signals (Yang and Liao, 1997). However, wavelet transforms are not yet recognized 
as a standard tool for analysis of HRV. 
The proposed research is designed to analyze cardiovascular responses to orthostatic 
stress using the combined knowledge from engineering (signal analysis), mathematics 
(statistical analysis), and physiology (cardiovascular system). The main objectives of this 
study are to: 
1) Develop a LBNP platform for testing methods of HRV measurement and analysis. 
2) Obtain data to test the hypothesis that cardiovascular responses and control mechanisms 
of humans under the orthostatic stress conditions are correlated to information contained 
in HRV data. 
3) Determine the reproducibility of HRV indices and cardiovascular parameters that are 
measured in response to a range of LBNP. 
4) Implement HRV analysis tools using statistical, power spectral density, and wavelet 
analysis techniques and assess the suitability of wavelet techniques as compared to the 
other two techniques for characterizing HRV. 
5) Evaluate the effects of gender and body size on orthostatic tolerance. 
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This study will demonstrate how knowledge from different fields such as engineering, 
mathematics, and physiology can be integrated for analysis of the cardiovascular system 
having potential benefits in practical applications related to orthostatic intolerance in patients. 
The results of this research will provide: 1) the reproducibility of HRV responses to LBNP, 
2) a comparison of wavelet and spectral analysis techniques as tools for assessment of 
physiological responses to LBNP, and 3) an increased understanding of gender and body size 
effects to control cardiovascular system under orthostatic stress condition. 
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II. LITERATURE REVIEWS 
2.1 Cardiovascular physiology 
2.1.1 Heart 
The heart is often compared to a highly interactive pump that communicates with the 
central nervous system to maintain homeostasis of the body. The heart consists of foiu* 
chambers - two atria and two ventricles. The atria send blood into the ventricles which send 
blood to the lungs and the systemic circulation system. The right side of the heart receives 
venous blood from the systemic circulation system (peripheral tissues) and drives this blood 
into the pulmonary circulation system to replenish the oxygen content and remove carbon 
dioxide from the blood. The left side of the heart receives blood from the lungs and sends 
this oxygen-rich blood into the systemic circulation system. The main function of the heart is 
to keep blood flowing through die circulatory system in the body. 
2.1.1.1 Electrical activity of the heart 
The heart generates rhythmic electrical impulses to contract the heart muscle 
(automaticity of the heart). These impulses are rapidly conducted throughout the heart by 
specialized conductive tissues (Figure 1). In normal conditions, an impulse (action potential) 
begins in the sinoatrial (SA) node, which has the capability of self-excitation. Impulses are 
spread into both atria through three intemodal atrial pathways and eventually converge at the 
atrioventricular (AV) node. The AV node and its associated conductive fibers delay the 
transmission of the cardiac impulses from the atria into the ventricles. This delay allows time 
for the atria to contract and shift their contents into the relaxed ventricles. The action 
potential then travels to the AV bundle, also known as the bimdle of His. The AV bimdle is 
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divided into two major bundle branches that radiate across the inner surfaces of the right and 
left ventricles (Martini, 1992). The bundle branches are divided into smaller branches and 
spread into the cardiac muscle fibers by way of specialized conducting cells, called "Purkinje 
fibers" (Guyton et al., 1973). As a result of this depolarization stimulus, heart muscle 
contraction occurs. This electrical activity of the heart can be measured by an 
electrocardiograph. 
An electrocardiograph is a valuable instrument to analyze the electrical activity of the 
heart. As the cardiac impulse passes through the atria and ventricles, electrical currents 
spread into the tissue surrounding the heart. The electrocardiograph records the electrical 
potentials generated by these currents; fluctuations in potential represent the sum of the 
action potentials of myocardial fibers (Figure 1) (Ganong, 1993). The normal 
Actign potsffliil 
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Figure 1. Conduction system of the heart and the electrical activity (Ganong, 1993). 
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electrocardiograph consists of a P wave, a QRS complex, and a T wave (Figure 1). The P 
wave represents the atrial depolarization preceding atrial contraction, the QRS complex 
represents the ventricular depolarization prior to ventricular contraction, and the T wave 
represents the ventricular recovery from the ventricular depolarization. Figure 2 illustrates 
the coupling of the electrical activity of the heart with its mechanical activity. 
eo 
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Figure 2. Events of the cardiac cycle (Martini, 1992). 
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2.1.1.2 Normal heart rate 
The average heart rate (HR) of normal adults is about 70 beats per minute (bpm) and 
can range from 35 to 190 bpm (Chou and Timothy, 1996; Guyton, 1991). During sleep, the 
HR diminishes by 10 to 20 beats (bradycardia) but can be accelerated (tachycardia) by 
stimuli such as emotion, exercise, and fever (Berne and Levy, 1997; Ganong, 1993). The 
normal HR varies with the respiration. During inspiration, HR increases and decreases 
during expiration. This is a normal physiological phenomenon (sinus arrhythmia) as 
described in the next section. 
The HR of trained athletes is often < 50 bpm at rest suggesting improved performance 
of the heart. Athletes have larger hearts and greater stroke volumes (SV) than nonathletes, 
but athletes have less HR resulting in relatively similar resting cardiac outputs (CO) at rest 
(Guyton, 1991). However, Hudson et al. (1987) have reported no significant difference in 
HR between trained females and untrained females. Gender and age also affect the normal 
HR. The elderly have faster HR than young adults and women have higher HR then men 
(Chou and Timothy, 1996). 
2.1.1.3 Neural control of the heart 
Though the heart has its own intrinsic control systems, the working effectiveness of 
the heart is highly adjusted by regulatory impulses from the central nervous system. The 
central nervous system has two divisions of the autonomic nervous system, sympathetic and 
parasympathetic, which have antagonistic effects on the heart. Both divisions of the 
autonomic nervous system irmervate not only cardiac muscle cells but also the S A and AV 
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nodes. However, the SA node is the primary region of vigorous influence by both divisions 
of the autonomic nervous system (Beme and Levy, 1997). 
In the absence of any neuro-humoral influence, the intrinsic HR in people is about 
100 to 120 bpm, e.g. heart transplant recipients. In the intact organism, responses to 
perturbation factors are evident in HR changes as the net effect of the parasympathetic 
(vagal), which slows HR, and the sympathetic, which accelerates HR. In resting conditions, 
the vagal influence is dominant resulting in lower HR than the intrinsic HR. However, the 
vagal activity declines and the sympathetic activity increases with increasing levels of 
exercise. The HR response to a change in parasympathetic activity is extremely rapid, 
occurring within a few milliseconds after vagal stimulation (Beme and Levy, 1997; 
Hainsworth, 1995). The response of recovery is a little slower than that of the onset. In 
general, HR returns to its previous level in less than 5 seconds after cessation of vagal 
stimulation. 
The alteration in HR in response to changes in sympathetic activity is much slower 
than that of parasympathetic activity. The onset of sympathetic stimulation increases HR 
progressively after about a 5-second latency period with HR reaching a steady level in 20 to 
30 seconds (Beme and Levy, 1997; Hainsworth, 1995). 
The sympathetic stimulation increases not only HR (chronotropic effect) but also 
contractility (inotropic effect) of the heart muscle; therefore, the CO and SV increase. By 
contrast, parasympathetic stimulation exerts a depressant effect by direct innervation via the 
vagus nerve. Parasympathetic stimulation causes delayed impulse initiation (effect on SA 
node) and conduction (effect on AV node) within the heart, resulting in a decreased HR and 
CO. It can also decrease the strength of cardiac muscle. However, due to the modest 
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distribution of vagal fibers on the ventricles, parasympathetic activity will decrease the 
strength of heart's contraction by only 20 to 30 per cent, while sympathetic activity can 
increase the contractility of the heart by over 100 per cent (Guyton, 1991). 
The rhythmical variations in HR occur in normal individuals with the phases of 
respiration; HR accelerates during inspiration and decelerates during expiration (Ganong, 
1993). During inspiration, not only filling of the heart but also the volume in lungs is 
increased, impulses in the vagi fi-om the stretch receptors in the atria and lungs inhibit the 
cardioinhibitory area in the medulla oblongata and cause HR to rise (Ganong, 1993). During 
expiration, the opposite effects occur. 
2.1.2 Circulatory system 
2.1.2.1 Blood flow 
The human body is composed of trillions of cells which need continuous oxygen, 
nutrients, and waste disposal to stay normal. The blood 1) transports dissolved gases such as 
oxygen to the tissues and removes carbon dioxide fi-om the tissues, 2) distributes nutrients to 
the tissues, 3) transports metabolic wastes firom tissues to excretion sites, and 4) delivers 
hormones to target tissues. Consequently, the blood has to be continuously in motion to 
maintain homeostasis. 
Blood, like other fluids, flows firom high-pressure areas toward the relatively low-
pressiure areas. The flow rate is directly proportional to the difference in pressure (AP) and 
inversely proportional to resistance (R) of the circulatory system. The difference in 
circulatory pressxire is the difference in the systemic circuit that begins at the left ventricle 
and ends at the right atrium. In general, the terms "blood pressure (BP)", which refers to the 
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arterial pressure, and "peripheral resistance (PR)", which is the resistance of the arterial 
system, are commonly used to describe blood flow. Blood flow can be described as: 
AP _ A5P F « or F w 
R PR 
The overall blood flow in the circulation is approximately 5 liters per minute when an 
adult is at rest; it is called the CO since the blood flow per unit time is the amount of blood 
pumped by the heart per minute (Guyton, 1991). The change in either HR or SV varies the 
CO since 
CO = HR X SV 
Cardiac output (ml/min) = Heart rate Cpm) x Stroke volume (ml) 
2.1.2.2 Regulation of the circulation 
Control of peripheral vascular function is accomplished by the interplay between 
intrinsic and extrinsic control mechanisms. Intrinsic control is the local regulation of blood 
flow based on the inherent physiological attributes of the tissues and organs. Extrinsic control 
is by the hormonal or autonomic regulation. 
2.1.2.2.1 Local regulation 
Most vessels have an intrinsic capacity to regulate their own blood flow 
(autoregulation). Two mechanisms have been proposed for this (Ganong, 1993; Guyton, 
1991): 
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1) The myogenic theory: This is the intrinsic response of smooth muscle of the blood vessel 
to stretch. As the pressure rises, the blood vessels are stretched and this causes the 
smooth muscle of vessel wall to contract. 
2) The metabolic theory: When blood flow increases, the excessive blood flow washes 
vasodilator substances out of the tissue; this will allow the blood vessels to contract. 
When blood flow decreases, vasodilator substances accumulate in the tissue. This will 
cause the blood vessel to dilate. 
In most tissues, the metabolic changes, including decreases in oxygen or pH (increase 
in ion concentration), increases carbon dioxide, and local release of nitric oxide, produce 
vasodilation. Some endogenous substances such as 5-hydroxytryptamine on certain sites and 
prostaglandins (F-series) along with thromboxane A2 are vasoconstrictors (Rowell, 1986). 
Temperature is one of the important local influences. Cooling below normal causes 
vasoconstriction and vasodilation occurs with warming above normal. Also, some potent 
substances released by endothelium may influence local vasomotor control. 
2.1.2.2.2 Hormonal regulation 
This is the regulation of the blood circulation by substances (hormones) formed by 
special glands or local tissue. Hormones are organic chemicals released from endocrine cells 
into the bloodstream. These hormones also regulate body systems to maintain homeostasis. 
However, many hormones act slowly on specific target organs and tend to be effective for 
long-term regulation. 
Catecholamines: Since some compounds of special hormones called catecholamines such as 
norepinephrine and epinephrine also function as neurotransmitters in the nervous system, it is 
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appropriate to describe these compounds as both hormones and neurotransmitters. 
Epinephrine comprises about 80 percent of the secretion of the total catecholamines released 
from the adrenal medulla into bloodstream, and the rest is norepinephrine (Martini, 1992). 
Epinephrine acts on Pi-adrenergic receptors, which are also stimulated by norepinephrine in 
the heart, this activation increases HR and contractile force fRowell. 1986). It stimulates 02 
receptors on coronary artery to dilate, causing increased blood flow (Ganong, 1993). In 
veins, epinephrine causes them to constrict, which forces blood out of the veins toward the 
heart (Rowell, 1986). 
In contrast to epinephrine, norepinephrine exists in plasma mainly due to leakage 
from sympathetic terminals into the bloodstream (Rowell, 1986). Norepinephrine constricts 
the blocd vessels in skeletal muscle and some organs via a receptors. Norepinephrine elicits 
an arterial baroreflex caused by increased arterial blood pressure. 
Other hormones: Other hormones such as aldosterone, angiotensin, antidiuretic hormone 
(ADH), atrial natriuretic peptide (ANP), erythropoietin, and renin are important for 
regulation of blood pressure and volume. When blood pressure or volume is changed, it 
afTects blood flow to the kidneys. Decreased blood pressure or volume causes reduced blood 
flow to kidneys. Kidneys are sensitive to blood flow reduction and release an enzyme called 
renin and a hormone called erythropoietin which stimulates the production and release of red 
blood cells to regulate blood volume (Martini, 1992). Renin acts on angiotensinogen, the 
globular protein secreted from the liver, to form the inactive polypeptide angiotensin I. This 
compound is converted to its active form called angiotensin II with passage through the 
lungs. Angiotensin n constricts arterioles directly and raises vascular resistance indirectly 
(Rowell, 1993). In the long term, angiotensin U stimulates the adrenal production of 
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aldosterone, a mineralocorticoid hormone that causes water retention at the kidneys and 
prevents further reductions in blood volume by increases in sodium reabsorption. Also, a fall 
in blood volume or pressure causes the posterior pituitary to release ADH or vasopressin. 
ADH causes the kidneys to reabsorb the water and decrease the amount of water lost. ADH 
also causes vasoconstriction which elevates blood pressure (Martini, 1992). 
Stretch of muscle fibers in the atrial wall by increased blood pressiu^e or volume 
releases ANP is released. AMP promotes the loss of sodium ions and water at the kidney, 
inhibits the secretions of some hormones such as ADH and aldosterone, and dilates blood 
vessels (Ganong, 1993). As a result, blood volmne and pressure are returned to the normal. 
2.1.2.2.3 Neural regulation 
Autonomic control is a powerful control mechanism of the circulation. It primarily 
acts by redistributing peripheral blood flow to different areas of the body and by affecting 
cardiac activity (Guyton, 1964). The sympathetic nervous system plays a major role in the 
regulation of the circulation, while the parasympathetic nervous system has a minor influence 
on the peripheral circulation system (Guyton, 1991). The sympathetic nerves innervate the 
central and peripheral vascular systems as well as the heart. However, the regulation of the 
HR by the vagus nerves is a major role of the parasympathetic nervous system in circulation 
(Guyton, 1991). Increases in sympathetic activity on the small arteries and arterioles 
increase local resistance and decrease the rate of blood flow through the tissues. 
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2.1.2.3 Baroreceptors 
Baroreceptors are stretch receptors that are sensitive to blood pressure. While some 
baroreceptors exist in the walls of large arteries of the neck and thoracic regions, 
baroreceptors are abundant in the walls of the internal carotid arteries and the aortic arch 
(Guyton, 1991). In general, three major baroreceptors are involved in cardiovascular 
regulation (Beme and Levy, 1997; Ganong, 1993; Guyton, 1991; Milner, 1990). These are: 
Carotid sinus baroreceptors monitor changes in blood pressure at the carotid sinus. These 
receptors are extremely important and sensitive because blood pressure at this location 
directly affects the blood flow to the brain. 
Aortic baroreceptors respond to changes in blood pressure within the ascending aorta. 
Stimulation aortic baroreceptor leads to reduced CO and fall in systemic blood pressure. 
Atrial baroreceptors respond to the blood pressure at the end of the systemic circuit (the vena 
cava and the right atrium). When blood pressure rises at these locations, baroreceptors in 
these regions stimulate the cardioacceleratory center, leading to increased CO until atrial 
blood pressiure returns to normal. 
The blood vessel deformation due to the arterial pressure in the carotid sinus and 
aortic arch stimulates baroreceptors in these regions. The firing rate of these baroreceptors 
are increased by an elevated blood pressure and decreased by a reduced blood pressure 
(Beme and Levy, 1997). In general, the carotid sinus baroreceptors are more sensitive than 
the aortic baroreceptors. 
Atrial baroreceptors along with baroreceptors in the ventricles and pulmonary vessels 
are called cardiopulmonary baroreceptors. These baroreceptors monitor blood volume in 
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cardiopulmonary regions. Activities of these receptors change peripheral resistance; 
stimulation of cardiopulmonary baroreceptors elicit changes in forearm resistance. 
Baroreceptors control CO and peripheral resistance to prevent large changes in blood 
flow and maintain normal blood pressure. When blood pressure rises, this stretches the 
baroreceptors, which transmit the impulse signals to the central nervous system. As the 
central nervous system receives the signals, they send "feedback" signals to the circulatory 
system via the autonomic nervous system to return blood pressure toward normal. 
Conversely, low pressure has opposite effects, causing the blood pressure to rise toward 
normal. 
When arterial blood pressure rises above the threshold point of the baroreceptors, 
increased output from the baroreceptors goes to the nucleus tractus solitarius (NTS) in the 
brain's cardiovascular center via the carotid sinus and vagus nerves. The output signal from 
the NTS travels to the cardioacceleratory center in the hypothalamus to inhibit cardiac 
activity. The signal stimulates the cardioinhibitory center in the medulla to reduce the rate 
and strength of the cardiac contractions, thereby lowering CO. The vasomotor center 
(paramedian reticular nucleus) also inhibits vasomotor activity, which leads to dilation of 
peripheral arterioles. The combination of a reduction in CO and a decrease in peripheral 
resistance results in a decrease in blood pressure. 
In contrast, if blood pressure becomes abnormally low, the reverse occurs. A 
reduction in barorecepor output causes signals to NTS which disinhibits the 
cardioacceleratory center, which results in increased afferent output to the SA node, AV 
node, and cardiac muscles (myocardium). The stimulation of the cardioacceleratory center 
produces an increase in HR, SV, and CO. Also, the signal inhibits the cardioinhibitory 
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center, resulting in increased HR. The output signal stimulates the vasomotor center which 
stimulates sympathetic neurons to produce a rapid vasoconstriction and increased peripheral 
resistance. The combined work of increased CO and peripheral resistance elevates blood 
pressure. 
The blood pressure rises during ventricular systole and falls during ventricular 
diastole. The maximum blood pressure measured during ventricular systole is called systolic 
blood pressure (SBP) and the minimum blood pressure at the end of ventricular diastole is 
called diastolic blood pressure (DBP). The difference between the SBP and DBP is called 
pulse pressure (PP). The mean arterial pressure (MAP) is the average pressure and estimated 
by adding one-third of the PP to the DBP. 
2.1.3 Lower body negative pressure (LBNP) 
LBNP has been widely used as a research tool to investigate die cardiovascular 
responses to orthostatic stress. LBNP induces the graded blood shifting to the lower body. 
This method produces similar cardiovascular effects as those produced during head up tilt 
(HUT). However, LBNP stimulates the cardiovascular regulation in a short time compared 
to HUT (El-Bedawi and Hainsworth, 1994; Halliwill et al., 1998; Lacolley et al., 1993; 
Lipsitz et al., 1990; Low et al., 1997; Rowell, 1986; Zoller et al., 1972). HUT shifts blood 
volume toward the lower body with a stationary base with existence of gravitational effect 
(hydrostatic pressure). LBNP shifts blood volume from the upper to the lower half of body 
with application of a subatmospheric pressure to lower body. The rate of shift of blood 
volume depends on the negative pressure around the lower body. LBNP generates the 
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similar cardiovascular reflexes as HUT, but in the absence of gravitational effects (Rowell, 
1986; El-Bedawi and Hainsworth, 1994). 
LBNP is applied using a small chamber, which encapsulates the lower body, with an 
air-tight seal around the waist. Negative pressure within the chamber is generated by a 
vacuum. An adjustable seat prevents caudal body movement due to the suction. The subject 
is in the supine position and any lower body movement is strongly discouraged since any 
muscle movement drives blood upward (blood movement by muscle pump). 
2.1.3.1 Cardiovascular responses to LBNP 
Many researchers have employed the LBNP technique using many different 
protocols. Interstudy differences include different initial negative pressure levels (typically 
from -1 to -10 mmHg), length of each stage of LBNP (range from 1 to 30 minutes), and 
increment of negative pressure stage (range from -1 to -10 mmHg) (Johnson et al., 1974; 
Ahmad et al., 1977; Frey et al., 1986; White and Montgomery, 1996; White et al., 1996). 
These different LBNP protocols result in different reflex mechanisms/or activities in 
cardiovascular system. Low initial negative pressures with a long interval time and small 
graded increments of negative pressure have a lower incidence of syncope because the 
cardiovascular system is able to adapt to new slowly changing environment. However, high 
initial negative pressure causes a high rate of syncope compared to the other protocols. 
At low levels of negative pressure, LBNP progressively decreases central blood 
volume and central venous pressure. Also, LBNP leads to reductions in forearm blood flow 
initiated by low-presstire baroreceptor activation without significant changes in other 
physiological parameters such as HR, MAP, and PP (Zoller et al., 1972; Johnson et al., 1974; 
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Rowell, 1986). It is believed that lower levels of LBNP cause stimulation of low-pressure 
barorecepors in the atria and the aortic arch. Further decreases in negative pressure unload 
high-pressure baroreceptors. This unloading is mainly due to further decreases in arterial 
pressure and a narrowing of PP. Compensation for the reduction in central blood volume by 
splanchnic vasoconstriction, increases in HR and fiirther reductions in forearm blood flow 
occurs (Figure 3) (Rowell et al., 1972; Johnson et al., 1974; Rowell, 1986). For example, 
Rowell et al., reported a 45% reduction in forearm blood flow, 32% fall in splanchnic blood 
flow, 30% increase in splanchnic vascular resistance, 28% fall in CO, and 51% reduction of 
SV during about 15 minutes of -50 and -70 mmHg of LBNP. Catecholamines such as 
norepinephrine and epinephrine in plasma increase with LBNP and plasma hematocrit and 
renin also increase with LBNP (Evance et al., 1999). These are mainly due to increases in 
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decrement of-1 mmHg/min for 50 minutes. Right, responses to LBNP from 0 to -40 mmHg 
by decrements of-10 mmHg (Rowell, 1986). 
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neural-hormonal compensation mechanism in cardiovascular system caused by the blood 
shift toward lower body generated by LBNP. These results support the idea that LBNP 
induces sympathetic activity. 
2.1.3.2 Gender difference to orthostatic tolerance 
Studies of orthostatic tolerance have focused primarily on men (Convertino et al., 
1990; Fritsch-Yelle et al., 1996; Lacolley et al., 1993). Lacolley et al. (1993) reported a 
significant increase in HR, peripheral resistance, and plasma concentration of norepinephrine 
and epinephrine with -40 mmHg LBNP. Frey et al. (1987) evaluated the responses of 45 
healthy women to LBNP levels of -30, -40, and -50 mmHg. LBNP induced a significant 
increase in HR and peripheral resistance, and a significant decrease in SV, CO, and SBP. 
Even though many studies have evaluated the cardiovascular reflexes to LBNP in 
both genders, relatively few have compared LBNP tolerance by gender. Orthostatic 
tolerance can be determined by increasing the magnitude of LBNP, prolonged standing, or 
head up tilt to presyncope which is manifested by a sudden increase in HR (tachycardia), 
sudden decrease in blood pressure, nausea, dizziness, and blurred sight (White et al., 1996). 
The results of orthostatic tolerance by gender were contradictory. Some studies 
reported women having less orthostatic tolerance than men (Hordinsky et al., 1981; Ludwig 
et al., 1987; White et al., 1996), women having similar orthostatic tolerance to men (Frey et 
al., 1986; Frey and Hoffler, 1988; Rahman et al., 1991), and even women having higher 
tolerance than men (Hudson et al., 1987). However, many studies concluded that women 
have less tolerance to orthostatic stress induced by LBNP, upright posture, and centrifugation 
(Ludwig and Convertino, 1994; Montgomery et al., 1977). It is believed these results are due 
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to men and women having different cardiovascular mechanisms and using different strategies 
to maintain blood pressure during an orthostatic challenge. White and Montgomery (1996) 
reported that women had an 83 % greater increase in blood volume in the pelvic region 
(P<0.05) than men with LBNP exposure. However, some researchers opposed this result and 
reported that increases in blood volume in the pelvic region in women was not a critical 
determinant of LBNP tolerance (Halliwill et al., 1998). Gotshall et al. (1991) reported a 
significantly greater decrease in SV, CO, and PP and greater increases in MAP and total 
peripheral resistance in men. 
In summary, the cardiovascular responses to maximum orthostatic stress were similar 
between genders, but women reached presyncope at lower level of LBNP. However, in the 
most reported studies, the women were significantly shorter and lighter than the men. 
Consequently, the males had bigger hearts and more blood volume than females. It is still 
unclear whether the differences seen in cardiovascular response mechanisms to orthostatic 
stress and orthostatic tolerance between genders are due to body size differences rather than 
the gender difference. 
2.2 Analysis of heart rate variability signal 
2.2.1 Heart rate variability (HRV) 
Evaluation of HR data, which is the most readily accessible cardiovascular signal, can 
yield useful information about cardiac health. HR is regulated by the interplay of neural, 
respiratory, circulatory, and hormonal influences. However, since the heart is predominantly 
controlled by neural regulation, neural activity can be deduced from the analysis of HRV. 
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Spectral analysis has been widely used as a tool to study the underlying patterns of 
the HR for determining the balance in autonomic nervous system. Early investigators 
identified peaks in the spectrum of HRV located at approximately 0.10 Hz in a low-
frequency range [LF; 0.04 - 0.15 Hz] and about 0.2 Hz in a high-frequency range [HF; 0.15 
- 0.4 Hz] (Akselrod et al., 1981; Appel et al., 1989; Mathias et al., 1993; Task Force, 1996). 
The low-frequency peak can be described as the response of the baroreceptor reflex, whereas 
the high-frequency peak is characterized as the respiratory frequency. 
Spectrum data are normalized to minimize the effect of changes in total power [TP; 
0.001 - 0.5 Hz] on the interpretation of the relative changes in LF and HF components. 
Normalized units are given as the relative value of LF and HF in proportion to the total 
power minus the very low frequency component [0.001 - 0.04 Hz] (Pagani et al., 1986; Task 
Force, 1996). The Task Force (1996) claimed that the use of normalized frequency 
components emphasizes the controlled and balanced behavior of the two branches of the 
autonomic nervous system. 
Pharmacologic blockade in conscious dogs and humans has been used to demonstrate 
the physiologic mechanisms involved in mediating HR fluctuations at these frequencies 
(Akselrod et al., 1985; Pagani et al., 1986; Pomeranz et al., 1985). These studies revealed 
that parasympathetic blockade abolished all heart rate fluctuations above 0.15 Hz and 
substantially reduced lower frequency HR fluctuations. Adding a beta blockade then 
removed the residual low frequency fluctuations. Thus, fluctuations at higher frequencies 
[above approximately 0.15 Hz] appear to be solely parasympatheticaily mediated, whereas 
fluctuations at lower frequencies [below 0.15 Hz] are jointly mediated by the sympathetic 
and parasympathetic nervous systems. 
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Dozens of studies have used spectral analysis of HRV under various physiological 
states. Those studies showed that enhanced sympathetic activity induced by standing, 
exercise, hemorrhage, hypotension, and orthostatic stimulus were associated with a marked 
increase in the low frequency component and with a decrease in the high frequency 
component of the spectra (Bulter et al., 1994; Pomeranz et al., 1985). Diminished areas of 
low and high frequency peaks have been seen in elderly people (Shannon et al., 1987). 
Patients with heart failure have depressed HRV; diminished power was seen at all 
frequencies greater than 0.2 Hz (Appel et al., 1989; Shannon et al., 1987). The HRV in 
patients with a transplanted heart exhibited reduced total power and a lack of distinct peaks 
in the power spectrum was commonly seen (Sands et al., 1989). 
After acute myocardial infarction, the low frequency component was significantly 
increased and the high frequency component was significantly decreased compared to those 
of normal people (Lombardi et al., 1987). Diminished HRV, assessed from 24-hour 
continuous electrocardiographs, was indicative of altered autonomic control and was a strong 
predictor of mortality in patients after myocardial infarction. Molgaard et al. (1991) 
suggested that low variability of HR (using statistical technique such as the deviation of R-R 
intervals) may indicate increased risk of sudden cardiac death, even in apparently healthy 
subjects (Mathias et al., 1993). They also proposed spectral analysis of HR may be a usefiil 
technique in assessing autonomic ftmction in patients with conditions related to autonomic 
failure such as diabetes and hypertension. 
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2.2.1.1 Sampling theorem 
The analysis of HRV begins with recording the electrocardiogram. The analog 
electrocardiograph output has to be digitized at a sufficiently high rate to faithfully 
reproduce the original analog signal. An inadequate sampling rate can lead to digitization 
errors known as "aliasing" (Oppenheim and Schafer, 1994; Orfanidis, 1996). While the 
sampling rate has to be high enough to avoid loss of information in the original signal, an 
excessively high sampling rate requires high quality instruments, more processing time, and 
enormous data storage space. 
According to the Nyquist sampling theorem, the sampling rate (/,) should be at least 
twice as high as the maximum frequency (/^) of the original signal in order to achieve 
adequate precision of the digitized signal, 
f > 2f . J s J max 
The minimum sampling rate allowed is called the Nyquist rate and diat is /, = 2 and the 
frequency at one-half the sampling frequency is called the Nyquist cutoff frequency 
(/max -fsytptist = /j ^ 2) (Orfanidis, 1996). If the Nyquist condition is satisfied in sampling the 
original signal, the continuous original signal can theoretically be reconstructed without 
aliasing from its sample sequence (Steams and David, 1996). 
2.2.2 Spectral analysis 
2.2.2.1 Power spectral density 
The main purpose of spectral analysis is to represent a signal by a sum of weighted 
sinusoidal functions and to characterize various signal soiu^ces. The weighting function is a 
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density of spectral components. The power spectral density (PSD) of a random process X(t)  
or X[n] is defined as 
- 2[^.,-(r)] = J" R^(r)ex^{-jcor)dT (Continuous case) 
ao 
= ^/?^[r]exp(-y<yT) (Discrete case) 
where /?.Y-(r) is the autocorrelation function (ACF) of X{t)  or X{n\  with lag T defined as 
R,{r)=s[X{t)X( t  + v)]  
R^{t\ = e{X{n\X{n + T]) 
and 3[*] indicates Fourier transform, o) means frequency, and £• is the expectation operator 
(Brown and Hwang, 1997). The PSD analysis describes the distribution of energy as a 
function of frequency of the signal (Kay, 1988). 
Note that in these equations the PSD is represented as either an infinite integral of or 
the sum of an infinite set of ACF values. If, however, stationarity of the signal can be 
assumed, the PSD of a signal can be based on a finite data set. A process or signal is 
stationary when its statistical properties, such as mean, variance, and probability density 
functions, do not vary with the time and when its autocorrelation function depends only on 
time lag (T) and does not vary in time (Brown and Hwang, 1997) (e.g. a sinusoidal function is 
an example of stationary signal). This underlying assumption of signal stationarity allows 
proper application of PSD methods for analysis of a signals of finite duration. 
Alternatively, an estimation of a PSD can be achieved using what are known as 
classical (non-parametric) and modem (parametric) spectral estimation methods. 
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2.2.2.2 Non-paxametric method 
The classical (non-parametric) method is based on a direct decomposition of the data 
to be analyzed into spectral components using Fourier analysis. Its processing speed is 
higher than the modern (parametric) method. The periodogram, which is the most popular 
way to estimate PSD, is a typical model of a non-parametric spectral estimator. The 
periodogram of a signal is defined by 
and the PSD estimation based on the periodogram is 
1 1 1 ^ 
Hm £ [—|3{X(0}|"]  =  hm s  [— ^X{t) Q\^{-jcot)dt 
(Continuous case) 
j" R^iT)ex^{-jcoT)dT 
= lim £[-^-
,v-.« "• jv 
s-\ 
2] Z[n] exp(-ycOT) 
n  s  0  
5^/2.,.[r]exp(-yiyr) 
] 
(Discrete case) 
(Brown and Hwang, 1997; Kay, 1988). 
However, due to the characteristic of periodogram that its variance does not decrease with 
data length even though the mean value of their data converges to the true PSD, the averaged 
periodogram is sometimes used to overcome this limitation (Kay, 1988). 
Many researchers employ the averaged periodogram (non-parametric method) to 
analyze the heart rate variability due to the simplicity of this method, (Akselrod et al., 1985; 
Baharav et al., 1995; Lipsitz et al., 1990; Ramaekers et al., 1998; Shin et al., 1997; Weise et 
al., 1995). 
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2.2.2.3 Parametric method 
The parametric method requires the rather onerous tasks compared to the non-
parametric method. The first step is to identify an appropriate model to be fit to the data. 
The second step is to estimate the parameters of the model using the data. The third step is to 
obtain the spectrum estimate of that model by substituting the parameter values into the 
theoretical PSD formula (Kay, 1988). The parametric method can yield I) improved 
resolution - smoother spectral components, 2) an accurate estimation of PSD even with a 
small number of data, and 3) easy postprocessing of the spectrum to evaluate distribution of 
sequence energy (Task force, 1996). 
The parametric method requires careful attention be used to verify tbe suitability of 
the selected model, because the accuracy of the model being applied to the data is quite 
important. An ideal model should have as few parameters as possible. The autoregressive 
(AR) model, the moving average (MA) model, and the autoregressive-moving average 
(ARMA) model are the three most common models used when implementing parameter 
estimation methods. The spectral estimate is based on one of these models. Consequently, 
the accuracy of the spectral estimates will be coarse if the model is inappropriate. Since 
there is no absolute right way to choose a model for a given signal, finding an adequate 
model is often troublesome. 
Autoresressive method: The AR spectral estimator, which is based on estimation of the AR 
parameters, is the most popular modeling approach to spectral estimation because it provides 
1) accurate estimation of spectrum and 2) better computational efficiency than other 
parametric methods. The AR parameters can be optimally predicted by solving the Yule-
Walker equations. Also, a maximum likelihood estimator can be used to estimate the best 
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AR parameters. Once a valid AR model is chosen, the spectral estimator can be obtained 
with less bias and a lower variability than non-parametric spectral estimate method (Kay, 
1988). The AR process of order p is 
AR{p):  z, = ^0 + + • • • + + s ,  
or 
= -  2  a[k]x[n -  /:]  +  \ \{n\  
k=\ 
where, £-,and vv(n] are noise terms with variance a'. 
The term "autoregressive" is used since a present value for the signal is expressed as a 
fimction of past values (weighted sum of past values) plus a noise term. The true PSD is 
^a[k]Qxp(-Jwk) I" 
and the estimate of the PSD is 
*=.0 
A 2 
SarU^)= ^  
^d[k]Q\^{- jwk)  I" 
*=0 
where, the (hats)" denote estimated values. 
A few researchers have studied the activity of the autonomic nervous system by means of AR 
frequency analysis of the HRV signal (Barbieri et al., 1997; Laitinen et al., 1998). 
Movim-Averase method: A MA model of order q can be expressed as: 
2, = ^  + dx^t-x  -  - • • • - 9^s,.^ 
or 
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4n]  = 
*=0 
The true PSD of a MA model is 
= o"' 
= a" 
]£6[A:]exp(-yM/A:) 
i=0 
1 + 2]6[A:]exp(-yw^) 
*=i 
and the estimate of its PSD is 
l + 2^i[^]exp(-yw^) 
t=i 
MA spectral estimation is valuable when the PSD is characterized by broad peaks (Kay, 
1988). The MA spectral estimator is generally not of sufficiently high spectral resolution for 
processes with narrowband spectral features. However, when the underlying process is 
wideband, the MA spectral estimator will be more accurate than Fourier based spectral 
estimator. None of the researchers have reported results based on use of MA spectral 
estimation techniques for the HRV, which is probably because HRV peaks do tend to be 
narrowband. 
Autoresressive - Movins - Average Model: The model 
is called a mixed autoregressive-Moving-Average model of order (p ,q)  and it can be 
expressed as 
t=l lfc=Q 
The PSD of the ARMA process is 
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^b[k] tx^{- jwk)  
k=Q 
= £T" 
J]a[^]exp(-yw^) 
k=Q 
1 +J]6[A:]exp(-ywA:) 
*=i 
l+X4^Jexp(-yw^)  
i=l 
ARMA model is a pole-zero model. This model is able to represent spectra with both sharp 
peaks and deep valleys. The estimate of the ARMA PSD is 
'AJiMA (Jw) = a' 
9 ^ 
5^6[A:]exp(-ywA:) 
*=0 
1 
= CT" 
^a[A:]exp(-yw^) 
M 
\  + Y,b[k]Qxp{- jwk)  
y 
l  + Y.^[k]Q\v{- jyvk)  
The main drawback associated with ARMA models, as with the other two parametric 
methods, is the difficulty associated with model selection. A very limited number of 
researchers have reported on the application of ARMA models to HRV (Triedman et al., 
1995). 
2.2.3 Wavelets analysis 
Even though Fourier transform based methods have been widely used in medical 
signal processing, these methods are not appropriate for analysis of signals containing 
transient components and/or non-stationary characteristics. This is particularly noteworthy. 
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because most of the statistical characteristics of medical signals are non-stationary although 
this technique is commonly used in this field. This is justified mathematically by dividing 
non-stationary signals into several blocks of short signal segments that do satisfy stationarity 
conditions. However, due to computation limitations that impose fixed size windows over 
the entire time-fi-equency plane, low spectral resolution tends to result, and ultimately this 
method fails to properly represent the signal of interest (Akay, 1995). 
Wavelets analysis techniques provide an alternative tool for analysis of non-stationary 
signals as well as stationary signals. Unlike a Fourier transform which provides only one-
dimensional description, a wavelet transform presents two-dimensional (time-fi-equency) 
description. Wavelets analysis is a windowing technique with variable-sized regions; short 
time intervals at high frequencies resulting in good time resolution and long time intervals at 
low frequencies resulting in good frequency resolution (Akay, 1995). 
The wavelet is mathematical tool for representing signal by a set of basis fimctions 
and all basis fimctions can be generated by a single scaling fimction, ^{x), and wavelet, 
y/{x), by scaling and translation (Bumis et al., 1998): 
= V"v{Vx-k)  
where j and k are integers. 
A set of basis fimctions is generated from the basic scaling function by scaling and 
translation: 
(p{x)  = Y,Sik)(p{2x-k)  
k 
y/{x)  = Y^h{k)(p{ lx-k)  
k 
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where g(A:)=(-l)*A(l-A:) is a scaling coefficient and h{k)  is the wavelet coefficient. 
i{/ (.r) is called a mother wavelet if it satisfies the following two properties: 
= 0 
—FLO 
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\\y/{t)\'dt < 
-<e 
The wavelet transform produces coefficients representing the correlation between the 
wavelet and small sections of the input signal, as a function of scale and translation. 
Continuous wavelet transforms operate every scale and translation whereas discrete wavelet 
transforms operate on scale and translation based on powers of two, called the dyadic 
sampling process. The wavelet coefficients of a signal /(.r) are: 
ao 
K.b = ¥a.b(^) 
—as 
with corresponding synthesis formula 
1 
where = ^x-b^  
'a.b^  
'\a\ 
in CWT 
\ a / 
r..tM = 2-''"-i^i2-''x-b) inDWT 
A uniquely attractive attribute of wavelet transforms is that at higher frequency since 
dilation of the base wavelet is small, wavelet transforms possess good time resolution but 
relatively poor frequency resolution. Conversely, at low frequencies where there is large 
dilation of the base wavelet, they have good frequency resolution but poor time resolution. 
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This variability of time-frequency resolution is a distinct merit of the wavelet transform 
(Burrus etal., 1998). 
The data can be decomposed into two components, approximations and details. 
/W = /l(/(x)) + D(/(x)) 
Consider an Z.-level decomposition, which can be written as 
f ix )  = W + W 
t k 
coefficients and dj,^ are 
m m 
where, 0 < J < L. 
Similarly, a recursive algorithm for synthesizing function can be derived based on its wavelet 
coefficients , and djj^ 
-  2m) + -  Im) 
m m 
The wavelet decomposition is an iterative process with successive slicing 
approximations into the desired lower resolution components. The wavelet packet is one 
method of wavelet decomposition. However, unlike general decomposition, which provides 
adjustable resolution of frequencies only at low frequencies, wavelet packets offer a richer 
range of the signal by decomposing both approximations (low frequencies) and details (high 
frequencies) into the next-level approximations and details (Figure 4 and 5). 
In practical application, when the input signal [Xin)] passes through two filters; one 
is  a  low pass  f i l ter  (  / /Q  )  other  i s  a  high pass  f i l ter  ( ) ,  producing two s ignals  [  A(n)  
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and D{n)  ]. This procedure results that the total output signal [ Y{n)=A{n)+D{n)]  will have 
twice data size of the original input signal ]. To correct this problem, wavelet analysis 
techniques use the operation of reducing the sampling rate called "downsampling" and is 
denoted by \1/ 2. This process keeps alternate samples by a factor of two; only the even 
indexed output samples are retained while the odd indexed output samples are discarded and 
mathemat ical ly  expressed by X^,(n)=X(2n) .  
Wavelet analysis conventionally provides a time-scale description instead of a time-
frequency description. However, the scale can be converted to the frequency easily since the 
scale is inversely related to the frequency; the wavelet becomes finer or compressed when the 
scale is lower and this corresponds to the high frequency on spectrum. In wavelet 
decomposition, the signal to be analyzed is decomposed into two signals in the first level; the 
low frequency component (0 - Hz) signal and the high frequency 
(fsyquist / 2 - fsyquui ^z) compouent signal. If signal has to be broken down tluther, each 
frequency component of signal is slice to the lower resolution of the low frequency 
components and the high frequency components of the decomposed signal in higher level. 
For example, at 2 level decomposition, 4 frequency component signal exists: [0 - /(4) 
HZ]J/v^^,/(4)-2X/^^„,,/(4) HZ],[2X/^^,,/(4)-3X/^^^,/(4) HZ], and 
[ 3X fuy i^uis,/(4) - 4X  /(4) HZ ] (Figure 4 and 5). 
Even though the number of applications using wavelets analysis on biomedical 
signals is rapidly growing, only a limited number of studies have reported the application of 
wavelets analysis techniques forHRV analysis (Ivanov et al., 1996; Pichot et al., 1999; 
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Wiklimd et al., 1997; Yang and Liao, 1997). Clinical interpretation of HRV based on 
wavelets analysis is not yet available. 
This study will be a pioneering study on the application of wavelet transforms to 
HRV with clinical interpretation. This study will provide results that allow diagnosis of the 
suitability and the efficiency of wavelets analysis use for HRV. 
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III. REPRODUCIBILITY OF AUTONOMIC AND 
CARDIOVASCULAR RESPONSES TO ORTHOSTATIC STRESS 
A paper to be submitted to the Journal of Applied Physiology 
Kichang Lee, Dwayne Buchanan, Alison B. Flatau, and Warren D. Franke 
ABSTRACT 
The reproducibility of the autonomic and cardiovascular responses to lower body 
negative pressure (LBNP) is surprisingly limited. We postulated that LBNP tolerance, 
autonomic, and cardiovascular responses to LBNP would be reproducible. To test this, 14 
active college age men underwent an orientation exposure and 2 trials of graded LBNP to 
presyncope or -100 mmHg, separated by 1 week. Heart rate, stroke volume, cardiac output, 
blood pressure and forearm blood flow were assessed, as was heart rate variability in both 
time and frequency domains. LBNP tolerance was lower in trial 1 than trial 2 (Cumulative 
stress index [CSI]: 1698 ± 171 vs 1938 ± 139 mmHg-min; P<0.05) but the CSI rehability 
estimate was high (0.87). The trial-to-trial responses to LBNP common to all subjects 
(LBNP < -60 mmHg and at test termination) did not differ between trials although systolic 
blood pressure was lower in trial 2 at test termination (105 + 3 vs 112 + 3 mmHg, P<0.05). 
Relatively high reliability estimates were found for the resting data (lowest: 0.60 for low 
frequency/high frequency ratio; highest: 0.94 for standard deviation of R-to-R intervals). 
Reliability estimates varied by parameter measured and LBNP stage but were generally 
similar to that seen at rest although they were lower at test termination [lowest: 0.23 for high 
frequency (abs) power, highest: 0.87 for cardiac output]. These data suggest that mean 
autonomic and cardiovascular responses to graded LBNP are consistent across trials. 
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individual LBNP tolerance appears reproducible but individual responses at test termination 
are variable. 
INTRODUCTION 
Lower body negative pressure (LBNP) is a common tool to induce orthostatic stress 
via graded central hypovolemia. The physiological responses to LBNP have been 
extensively studied and reviewed (2, 18,26). However, investigations of the reproducibility 
of the cardiovascular and autonomic responses to this stress have been surprisingly limited. 
In the previous two studies found in the literattire, reproducibility of LBNP tolerance ranged 
from r = .64 to .93 with greater familiarization to LBNP testing associated with greater 
reproducibility (6, 15). However, reproducibility of the cardiovascular responses was either 
not reported (6) or limited to blood pressure and heart rate at LBNP of < -40 mmHg (15). 
In recent years, the engineering technique of power spectral density (PSD) analysis of 
heart rate variability (HRV) has become increasingly used to analyze autonomic nervous 
system responses to orthostatic stress (4, 7, 8). Increases in sympathetic nervous system 
activity and decreases in parasympathetic activity seen with graded LBNP can be reflected 
by changes in PSD of HRV (4, 8). Analysis of HRV via PSD is an attractive tool because it 
can provide insight into the autonomic modulation of the heart using data collected in a 
noninvasive and unobtrusive manner. The reproducibility of HRV has, in some contexts, 
been evaluated. Healthy resting subjects displayed acceptable reproducibility of HRV in 
both time and frequency domains (5, 19). Similar observations were reported with tilt table 
testing (5, 12,13,24, 25, 31). However, the reproducibility of the PIRV responses to LBNP 
has not been documented. While the HRV responses to one form of orthostatic stress, tilt 
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table, have been shown to be reproducible, it is uncertain whether these findings can be used 
as evidence of reproducibility for another form of orthostatic stress, LBNP. Moreover, in 
the cited tilt table studies, breathing frequency of the subjects was not controlled. Breathing 
frequency can have profound effects on HRV (3); not controlling for this variable necessarily 
limits comparisons. Lastly, while the cardiovascular responses to tilt testing and LBNP can 
be qualitatively similar, these different modalities should not be considered 
"interchangeable." For example, LBNP avoids use of anti-gravity muscles that are almost 
invariably activated during tilt table testing (2). The degree of venous pooling is proportional 
to the LBNP while it is proportional to the sine of the angle of tilt used with the other 
modality (2). Consequently, good reproducibility with tilt table tests may not be reflective of 
LBNP testing. 
Because data on the reproducibility of the cardiovascular responses to sub- and 
maximal LBNP are sparse and data on the reproducibility of the HRV responses to this 
stressor have not been reported at all, we performed the present investigation in order to 
determine the reliability of these tools commonly seen in hemodynamic laboratories. 
METHODS 
Subjects 
Healthy college-age men (n = 15) volunteered to participate as subjects in this study. 
All subjects were verbally informed of the intent and procedures of the study with written 
consent obtained prior to data collection. All protocols and procedures were approved by the 
Himian Subjects Review Committee of Iowa State University. 
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Subjects visited the laboratory three times. The first session included completion of a 
medical history questionnaire, a physical activity questionnaire to estimate VOamax 
(correlation coefficient = 0.85; [9]) and determination of anthropometrics, including body 
composition estimated from the sum of three skinfold thickness measurements (10). They 
were also oriented to the LBNP chamber. Subjects were placed in the LBNP chamber and, 
following a 6 minute resting period, were exposed to 10 mmHg reductions in pressure every 
2 minute until completion of-50 mmHg. Throughout this period, they practiced breathing at 
the desired fi-equency of 0.2 Hz. The second and third sessions entailed the administration of 
graded LBNP to presyncope or -100 mmHg. Each session was separated by one week and 
administered at the same time of day. Subjects were instructed to refi-ain from consuming 
caffeine and alcohol containing products and from performing vigorous exercise 24 hours 
prior to each maximal LBNP test. 
Maximal LBNP testing protocol 
Following instrumentation, each subject was placed supine in the LBNP chamber, 
sealed at the level of the iliac crest, and supported with an adjustable bicycle saddle for 
stabilization. After a 15 minute resting control period at ambient barometric pressure (0 
mmHg), negative pressure was imposed in 10 mmHg increments every 6 minutes imtil either 
completion of the test at -100 mmHg or the onset of signs and symptoms of presyncope. 
Indicators of impending presyncope included a drop in systolic blood pressure (>25 
mmHg-min'), progressive reduction in systolic blood pressure (to <80 mmHg), a sudden 
decrease in heart rate (>15 beats-min"') or subject symptoms such as light-headedness, 
nausea, sweating, dizziness, or gray-out (blurred vision). Throughout testing, subjects 
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breathed at a frequency of 0.2 Hz (12 breaths-niin"', 2.5 seconds expiration, 2.5 seconds 
inspiration) using visual cues to maintain the desired rate. Subjects were frequently 
instructed to avoid any leg muscle movement and to remain quiescent during the LBNP 
trials. 
Measurements 
Subjects were instrumented for the measurement of heart rate (HR), blood pressure, 
forearm blood flow, and stroke volume. HR was acquired beat-to-beat using a lead n 
electrode configuration (Model 1500B electrocardiograph, Hewlett-Packard, Andover, MA). 
Blood pressure was assessed beat-to-beat using a Finapres (Ohmeda, Englewood, CO) placed 
on the right middle finger. These values were compared and referenced to resting values 
assessed by an automated sphygmomanometer (Dinamap 9300, Critikon, Tampa, FL) placed 
on the right arm at the beginning of the test. 
Forearm blood flow was assessed every 20 s using venous occlusion 
plethysmography (32; EC 5R, D.E. Hokanson, Bellevue, WA). The mercury-in-silastic 
strain gauge was placed ~l/3 the distance from the olecranon process to the ulnar styloid 
with hand blood flow occluded throughout the measurements. Stroke volume was 
determined every minute using impedance cardiography (Minnesota Impedance Cardiograph 
Model 304-B, Surcom, Minneapolis, MN). The continuous HR and impedance cardiograph 
signals were recorded with a personal computer. Cardiac output was calculated with 
commercially available software (Microtronics Corp., Chapel Hill, NC) using ensemble R-
wave averaging on 55 s of data acquired in each minute period. The analog outputs of the 
electrocardiogram and Finapres were digitized and stored in data files on a personal 
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computer using an anti-aliasing filter and amplification unit with a 1000 Hz sampling rate 
(AT-MI016-L9, SCXI 1000, and SCXI1121, National Instrumentation, Austin, TX). 
Assessment of heart rate variability 
The heart rate data were processed to detect the R-R intervals using an algorithm 
based on the modified threshold method. The R-R intervals were manually inspected for 
missing or ectopic beats; if found, these were validated manually. HR, mean of R-to-R 
intervals (RR intervals), and standard deviation of R-to-R intervals (SDRR) were studied for 
time domain analysis. The HRV spectrum was calculated with Welch's averaged 
periodogram method using a stationary 256 R-R interval for the rest period and each level of 
LBNP. Due to the importance of stationarity (the statistical ftmction describing the data as 
not depending on time) of data for spectral analysis, the Dickey-Fuller test was performed to 
test stationarity of the HRV data (27). In addition, to ensure stationarity, the first minute of 
HRV data of each level of LBNP was excluded fi-om the analyses. 
The HRV spectral power associated with different frequency bands of response was 
calculated by integrating the amplitude of the spectrum over the desired frequency range. 
Total power for each subject was defined as the area under the HRV spectrum between the 
frequencies of 0.001 to 0.5 Hz. The low frequency (LF) component of the spectrum was 
between 0.04 - 0.15 Hz and the high frequency (HF) component was between 0.15 - 0.40 Hz 
(29). Data were subsequently normalized (21,29) to minimize the effect of reductions in 
total power on the interpretation of the changes in LF and HF that occur with LBNP. HF is 
indicative of the parasympathetic nervous system, or vagal, influence on HRV while the LF 
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likely reflects both parasympathetic and sympathetic modulation of HRV (23, 29). The 
LF/HF ratio served as an indicator of sympathetic nervous system activity (21). 
Statistical Analyses 
LBNP tolerance was quantified by the cumulative stress index (CSI; 17) and the 
LBNP tolerance index (LTI; 16). CSI, sum of the products of negative pressure and minutes 
of each stage, is more commonly used as an index of comparison in LBNP tests; however, it 
has curvilinear characteristics while LTI, sum of products of the change in LBNP and 
minutes of each stage, is linear and has a higher correlation with central venous pressure 
(16). Mean arterial pressure (MAP) was calculated as the sum of diastolic blood pressure 
and 1/3 pulse pressure. Forearm vascular conductance (FVC) was calculated as forearm 
blood flow/MAP and total peripheral conductance (TPC) as cardiac output/MAP. For 
statistical analysis, mean autonomic and cardiovascular responses for the last five minutes (2 
to 6 min) of each level of LBNP common to all subjects (< -60 mmHg) were determined and 
the mean of the last 3 minutes of LBNP tolerated (END). Paired t-tests were used to 
compare the resting data and LBNP tolerance between the 2 trials. The mean stage and END 
data were evaluated using two-way (stage by trial) repeated measures analysis of variance. 
Post hoc comparisons were made using the Student-Newman-Keuls procedure. Statistical 
significance was accepted at P<0.05. Data are presented as means ± SEM. 
An estimate of internal consistency (Cronbach a coefficient; 30) was calculated to 
assess the reproducibility of each variable at each stage across trials. Morrow and Jackson 
(20) argue that significance testing of reliability is dependent on sample size and therefore of 
little practical use. We have therefore followed their recommendation of reporting the 
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reliability coefficients and letting the reader judge the acceptability of the results. For 
reference, some (14) have suggested that reproducibility is considered to be acceptable if 
coefficients range from 0.41 to 0.60, good if coefficients range from 0.61 to 0.80, and 
high/excellent if > 0.81. 
RESULTS 
One subject was excluded from the study due to excessive ectopic beats and a second 
subject did not retxmi for the second LBNP test. The characteristics of the remaining 14 
subjects were 24 + I y, 177 + 2 cm, 84 + 5 kg, 11 + 1 %fat with an estimated V02niax of 50.4 
+ 1.7 ml-kg''-min'' (9). All results are based on these 14. 
Resting data 
A summary of the baseline HRV and physiological characteristics for the subjects in 
the two trials is presented in Table 1. During trial 1, the subjects had higher resting systolic 
and diastolic pressures (P<0.05) resulting in higher MAP (P<0.001). Higher HR and lower 
mean RR and SDRR were also seen with trial 1 (P<0.05). Absolute values of total power, 
LF and HF were higher in trial 2 than trial 1. However, LF and HF in normalized units and 
the LF/HF ratio did not differ significantly between the two trials. 
[INSERT TABLE 1 HERE] 
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LBNP tolerance 
Tolerance was lower in trial 1 than trial 2 (CSI: 1698 ± 171 vs 1938 ± 139 
mmHg-min; LTI: 404 ± 21 vs 437 ± 15 mmHg-min; both P<0.05). These values equate to 
the subjects terminating testing after 4 minutes at -70 mmHg LBNP in trial 1 and 2 minutes 
at -80 mmHg in trial 2. Only one subject completed -100 mmHg in both trials. Others 
stopped at various level of LBNP because of presyncopal symptoms, generally due to nausea 
or gray-out, accompanied by declines in systolic blood pressiore. 
Cardiovascular responses to LBNP to -60 mmHg 
MAP changed with LBNP (P<0.001) but the between-trial difference in resting MAP 
was preserved (P<0.05; Fig. 1). MAP decreased at -10 mmHg of LBNP then increased at > -
20 mmHg of LBNP, however, it decreased again at - 60 mmHg of LBNP (P<0.05). Cardiac 
output decreased below rest at > -10 mmHg of LBNP (P<0.001; Fig. 1). As with MAP, the 
slight but statistically significant difference in resting HR remained throughout LBNP. 
However in both trials, HR increased similarly above rest at > -20 mmHg of LBNP (P<0.05; 
Fig. 2). Stroke volume declined similarly with each increase in LBNP in both trials 
(P<0.001;Fig. 2). 
The FVC responses to LBNP did not differ between the two trials with FVC 
decreasing below rest at > -10 mmHg (P<0.001; Fig. 3). TPC significantly decreased with 
LBNP, falling below rest at > -10 mmHg of LBNP (P<0.001; Fig. 3). 
[INSERT FIGURES 1, 2, and 3 HERE] 
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Autonomic responses to LBNP to -60 mmHg 
Responses of the time domain HRV indices are shown in Fig. 4. In both trials, mean 
RR interval decreased significantly below rest at > -20 mmHg of LBNP (P<0.05) while 
SDRR decreased below rest at > -30 mmHg of LBNP (P<0.05). RR was higher at rest in trial 
2 and remained that way thj-oughout LBNP; the resting difference in SDRR was maintained 
at LBNP <-40 mmHg (P<0.05). Figure 5 shows the HRV indices in the frequency domain. 
Autonomic modulation of HRV changed significantly with LBNP in both trials (P<0.001). 
In both trials, the indicator of parasympathetic activity, normalized HF, decreased below rest 
at > -20 mmHg of LBNP (P<0.05). LF responses paralleled HF but were directionally 
opposite due to normalization (29). The indicator of sympathetic activity, the LF/HF ratio, 
increased significantly above rest at > -20 mmHg of LBNP (P<0.05). 
[INSERT FIGURES 4 and 5 HERE] 
END data 
A summary of the autonomic and physiological characteristics seen at test 
termination is presented in Table 1. There was no Trial main effect for any variable other 
than MAP in trial 1 being higher than trial 2 (P<0.05). At END, all the autonomic and 
cardiovascular indices differed significantly from rest (P<0.05) except for MAP and the 
absolute expression of LF. 
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Reproducibility 
Table 2 summarizes the alpha coefScients as reliability estimates of each variable at 
each stage of LBNP. All the resting data demonstrated good (>0.61) reproducibility. The 
cardiovascular parameters measured throughout LBNP showed acceptable (>0.41) or high 
(>0.81) reliability except MAP at -30 mmHg and cardiac output and TPC at -40 mmHg. In 
response to LBNP, the reproducibility of HR, mean RR, and SDRR was consistently high. 
Normalized LF, HF, and LF/HF ratio showed acceptable reproducibility throughout the 
LBNP test. Although LBNP tolerance changed from trial 1 to trial 2, diere was excellent 
reproducibility in this response; when quantified as CSI, the reliability coefficient was 0.87 
and, with LTI, was 0.83. However, at END, there was greater variability across trials in the 
cardiovascular and autonomic responses, especially in HRV assessed in the frequency 
domain. 
[INSERT TABLE 2 ABOUT HERE] 
DISCUSSION 
In this study, we assessed the reproducibility of LBNP tolerance and the autonomic 
and cardiovascular responses to submaximal and maximal LBNP. This study was unique in 
that it comprised the most extensive reliability assessment of these responses to date. 
Moreover, it was the first to assess the reproducibility of HRV responses to LBNP. The 
major findings of this study are that both LBNP tolerance and the autonomic and 
cardiovascular responses to submaximal LBNP are reproducible. However, the lower 
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reliability coefficients seen at END for the HRV data suggest that these individual responses 
at test termination can be variable. 
A high reliability estimate (a = 0.87 in CSI) suggests excellent reproducibility of 
LBNP tolerance. Our findings are consistent with previous studies where correlation 
coefficients for the comparisons of LBNP tolerance across two tests exceeded 0.70, ranging 
from 0.71 (15) to 0.79 (6). However, neither study indicated the type of correlation 
coefficient used; it is unclear whether they used the inappropriate interclass correlation or the 
more appropriate intraclass correlation coefficient (30). Regardless, Lightfoot and colleagues 
(15) noted that this correlation increased with repeated assessments. Using 4 maximal LBNP 
trials separated by 72 hours, the correlation between the third and fourth trials was 0.93 
although the maximal negative pressure tolerated varied less than 8% over the 4 trials. In the 
present study, the maximal negative pressure tolerated was 11% lower in trial 1 than trial 2. 
Reproducibility of the cardiovascular responses to submaximal LBNP 
When exposed to the graded LBNP, subjects in both trials experienced increases in 
HR and declines in cardiac output, stroke voliune, FVC, and TPC. These group responses 
did not differ between trials and the intrasubject responses were quite consistent. These 
responses were similar to those usually seen with LBNP (1, 2, 7,11, 26). However, MAP 
increased slightly but significantly in both trials at levels of LBNP > -20 mmHg. This was 
caused mainly by increases in diastolic blood pressure which were likely due to increases in 
systemic vasoconstriction. 
All the cardiovascular parameters showed parallel changes in the two trials 
suggesting similar group responses between both trials. Reliability estimates of the 
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cardiovascular variables were quite good except for the LBNP stages of-30 and -40 mmHg. 
At -30 mmHg, reliability of MAP was low while reliability of cardiac output and TPC was 
low at -40 mmHg. However, the etiology of this reduced reliability is uncertain; it may 
reflect differences in the magnitude of arterial baroreceptor unloading between trials and, 
therefore, sympathetic nervous system activity. Stroke volume responses to LBNP parallel 
central venous pressure responses (22). While stroke volume at -30 mmHg and —40 mmHg 
was statistically similar in both trials, these stages demonstrated the largest mean difference 
between trials. Therefore, the relative influences of cardiopulmonary and arterial 
baroreceptor unloading on these cardiovascular responses may have differed between trials at 
these stages, resulting in reduced reliability estimates for cardiac output and TPC. Despite 
the use of an orientation session to expose the subjects to LBNP of this magnitude, these low 
estimates may also reflect continuing adaptation of our subjects to repeated LBNP exposures. 
The HR responses to LBNP were virtually parallel across trials. This was reflected by 
excellent reliability estimates and reiterates the findings of others (5, 12, 13, 24, 25) where 
reproducibility of HR at rest and in response to tilt table testing was found to be quite good. 
Reproducibility of the autonomic responses to submaximal LBNP 
In both trials, subjects at rest had lower LF than HF, suggesting higher 
parasympathetic activity, and LF/HF ratios < I suggesting low sympathovagal balance. This 
result is consistent with previous studies of resting HR and HRV (4, 19) and suggests that 
parasympathetic activity is predominant at rest. However, others have reported different 
results, such as LF/HF ratio > 1 at rest, suggesting a lower influence of the parasympathetic 
nervous system (5, 28). It is imknown whether these other results were affected by 
52 
processing of non-stationary HRV data, inadequate control of respiratory frequency, or 
simply differences between the subject groups. 
The RR interval and SDRR decreased with increases in LBNP which is consistent 
with the finding that LBNP reduces vagal activity (4, 7, 8). Similar results with the 
frequency domain analysis of HRV were also seen. The parasympathetic nervous system 
indicator, HF, decreased with increases in LBNP and became significantly less than rest at > 
-20 mmHg of LBNP while LF and the LF/HF ratio increased above rest at > -20 mmHg, 
suggesting increasesed in sympathetic activity with increases in LBNP. 
In this study, both time and frequency domain indices of HRV showed parallel 
increases in the two trials, indicating good reproducibility of these indices with submaximal 
LBNP. The time domain parameters, including HR, showed consistently good reliability 
(a>0.78) with LBNP to -60 mmHg. HRV parameters in the frequency domain also showed 
good reproducibility, although the normalized expressions of LF and HF seemed to have 
greater internal consistency. At -30 mmHg, the reliability estimates of total power, LF (abs), 
HF (abs) and the LF/HF ratio were lower than those seen at higher and lower levels of 
LBNP. These data did not differ significantly between the two trials, although the mean 
difference between the two trials was the largest at this stage. As previously alluded to, this 
may reflect differences in the autonomic modulation of heart rate due to differences in the 
magnitude of arterial baroreceptor unloading and, therefore, sympathetic nervous system 
activity. More likely, it reflects between-trial differences in the total power seen at -30 
mmHg. Normalizing LF and HF reduces the influence of changes in total power on LF and 
HF (29) and the reliability estimates for these variables were much better than the absolute 
expressions of LF and HF at this stage. 
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Physiological responses and reproducibility to LBNP at test termination. 
At test termination, the cardiovascular responses demonstrated good reliability 
estimates although estimate for MAP was acceptable. In the minute leading to test 
termination, MAP dropped quite quickly, mainly due to sudden decreases in systolic blood 
pressure. While this response was consistent with that seen by others (7, 25), it varied 
considerably between trials. This consequently negatively influenced our reliability estimate 
for MAP at END. 
At END, HR increased and, consequently, RR interval decreased significantly above 
rest with decreasing SDRR. Likewise, reductions in HF below rest and marked increases in 
LF and LF/HF ratio at END suggested higher sympathetic and lower parasympathetic 
activities at test termination. The reliability estimates for the HRV data were better for the 
time domain indices than the firequency domain indices but were modest, at best, for all 
indices. This poor reproducibility may be due to marked variability in the individual 
responses to impending syncope. PSD analysis requires use of enough data points for 
adequate resolution of the HRV signal and stationarity of the data. It is inappropriate to 
perform PSD on the rapidly changing HRV seen at test termination. Doing so necessitates 
analysis of fewer data points which reduces the resolution of the PSD and because of the 
changing HRV, violates the assumption of stationarity critical to PSD analysis. This 
intraindividual variability, and our use of256 HRV data points for END, may therefore have 
negatively influenced the reliability of the frequency domain indices more so than the time 
domain indices. 
In summary, the present study evaluated the cardiovascular responses and 
reproducibility of these responses to submaximal and maximal LBNP while concurrently 
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assessing changes in the autonomic modulation of HRV. This work extends previous 
research assessing the reproducibility of these responses to tilt table testing (5, 13, 21), stand 
tests (23) or limited levels of LBNP (6, 15). Our data suggest that the cardiovascular and 
autonomic responses at rest and to submaximal levels of LBNP are reproducible. Likewise, 
the magnitude of LBNP needed to evoke test termination and the cardiovascular responses 
seen at this level are also reproducible. The intraindividual HRV responses to maximal 
LBNP appear to be more variable than is desirable. Nevertheless, the time domain indices of 
HRV at test termination appear to have much better reproducibility than that of the frequency 
domain indices. 
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HGURE LEGENDS 
Figure 1. Mean arterial pressure and cardiac output responses at rest and to lower body 
negative presstire (LBNP) to -60 nutiHg. * P<0.05 vs rest; t P<0.05 vs previous 
stage for both trials; % trial 1 vs trial 2. 
Figure 2. Heart rate and stroke volume responses at rest and to lower body negative pressure 
(LBNP) to -60 mmHg. See Fig. 1 for symbols. 
Figure 3. Forearm vascular (FVC) and total peripheral conductance (TPC) at rest and to 
lower body negative pressure (LBNP) to -60 mmHg. See Fig. 1 for symbols. 
Figure 4. Mean R-R interval and standard deviation of the R-R interval responses at rest and 
to lower body negative pressure (LBNP) to -60 mmHg. See Fig. 1 for symbols. 
Figure 5. High frequency (in normalized units) and the LF/HF ratio responses at rest and to 
lower body negative pressure (LBNP) to -60 mmHg. See Fig. 1 for symbols. 
Table 1. Resting cardiovascular and heart rate variability data. 
Rest Test Termination 
Variable Trial 1 Trial 2 Trial 1 Trial 2 
Cardiac output (I min"') 8.04 + 0.50 7.86 + 0.39 4.36 + 0.36 4.53 + 0.33 
Stroke volume (ml beaf') 128.3 + 8.7 130.83 + 7.2 45.4 + 3.6 44.6 + 3.0 
Systolic blood pressure (mmHg) 122.7 + 1.8 117.7 + 1.1 * 112.2 + 2.5 104.8 + 2.6 t 
Diastolic blood pressure (mmHg) 68.4 + 1.9 61.3 + 1.3 * 73.1 + 2.2 71.7 + 2.3 
Mean arterial pressure (mmHg) 86.5 + 1.7 80.1 + 1.0 * 86.1 + 2.2 82.7 2.1 
Forearm blood flow (ml-dP'-min'') 4.4 + 0.5 4.5 + 0.5 2.7 + 0.3 2.5 + 0.2 
Forearm vascular conductance (units) 0.051 + 0.006 0.057 + 0.006 0.030 + 0.004 0.031 + 0.003 
Total peripheral conductance (units) 0.093 + 0.005 0.099 + 0.005 0.051 + 0.005 0.055 + 0.004 
Heart rate (beats min ') 64.4 + 2.2 61.3 + 2.0 • 108.1 + 6.3 103.2 5.1 
RR interval (ms) 945.1 + 31.7 993.6 + 30.7 • 577.1 + 30.2 598.6 + 25.3 
SDRR (ms) 64.4 + 8.9 81.9 + 10.2 * 37.8 6.2 41.4 + 5.3 
Total power (s^-Hz ' • 1000) 2.299 + 0.061 3.869 -t- 1.000 • 1.068 + 0.387 1.339 + 0.300 
Low frequency (s^ Hz ' lOOO) 0.638 + 0.190 1.000 + 0.330 * 0.622 + 0.259 0.700 + 0.158 
High frequency (s^ Hz ' lOOO) 1.158 + 0.361 1.980 + 0.590 * 0.159 + 0.070 0.255 + 0.087 
Low frequency (nu) 39.7 + 2.8 35.9 + 3.4 74.8 + 4.7 73.6 + 3.7 
High frequency (nu) 57.5 + 2.8 60.9 + 3.2 18.7 + 2.2 22.9 + 3.3 
LF/HF ratio 0.74 + 0.08 0.65 + 0.09 5.23 + 0.87 4.63 + 0.86 
* P<0.05 Trial 1 vs Trial 2 at rest; t P<0.05 Trial 1 vs Trial 2 at test termination. 
Table 2. Reliability estimates to submaximal and maximal lower body negative pressure. 
Variable 
Lower Body Negative Pressure (mrnHft) 
Rest -10 -20 -30 -40 -50 -60 END 
Cardiac output (I min ') 
Mean arterial pressure (mmHg) 
Forearm vascular conductance (units) 
Total peripheral conductance (units) 
Heart rate (beats min"') 
RR interval (ms) 
SDRR (ms) 
Total power (s^ Hz ' 1000) 
Low frequency (s^-Hz"'-1000) 
High frequency (s^ Hz ' lOOO) 
Low frequency (nu) 
High frequency (nu) 
LF/HF ratio 
0.74 0.86 
0.65 0.75 
0.76 0.71 
0.78 0.82 
0.91 0.92 
0.90 0.93 
0.94 0.94 
0.85 0.93 
0.90 0.89 
0.81 0.89 
0.67 0.89 
0.65 0.77 
0.60 0.74 
0.88 0.86 
0.54 0.33 
0.68 0.71 
0.89 0.76 
0.89 0.87 
0.91 0.91 
0.84 0.78 
0.65 0.51 
0.58 0.46 
0.67 0.46 
0.76 0.86 
0.77 0.87 
0.80 0.60 
0.29 0.55 
0.66 0.59 
0.58 0.65 
0.29 0.51 
0.88 0.93 
0.90 0.95 
0.80 0.85 
0.63 0.78 
0.77 0.56 
0.83 0.82 
0.91 0.74 
0.91 0.79 
0.79 0.78 
0.52 0.87 
0.68 0.50 
0.46 0.64 
0.42 0.86 
0.93 0.76 
0.90 0.76 
0.85 0.55 
0.71 0.34 
0.76 0.37 
0.79 0.23 
0.41 0.48 
0.76 0.45 
0.92 0.66 
END denotes responses seen in the last three minutes preceding test termination. 
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IV. GENDER DIFFERENCES IN THE AUTONOMIC RESPONSES 
TO ORTHOSTATIC STRESS 
A paper submitted to the Journal of Clinical Science 
Kichang Lee, Warren D. Franke, and Alison B. Flatau 
ABSTRACT 
We hypothesized that gender differences in the autonomic responses to orthostatic 
stress may underlie differences in orthostatic tolerance. To test this, cardiovascular and 
autonomic responses to graded lower body negative pressure (LBNP) to syncope were 
studied in 8 men and 7 women matched for age, height and body surface area. LBNP 
tolerance was less in women than the men (Cumulative Stress Index: 1246 ± 132 vs 2206 ± 
334 mmHg«min; P<0.05). At rest, heart rate (HR) and heart rate variability (HRV) indices 
were similar between genders. However, mean arterial pressure was 2 ± 1 mmHg lower 
(P<0.05). In both groups, HR increased above rest at >-40 mmHg of LBNP (P<0.05). Mean 
arterial pressure fell below rest at LBNP > -30 mniHg (P<0.05) in women but not in men. 
Autonomic modulation of HRV, assessed via spectral analysis, was similar between groups 
at rest. The high frequency component of the spectrum, an indicator of parasympathetic 
nervous system activity, decreased below rest at LBNP > -40 mmHg in the men while 
decreasing only at presyncope in the women (P<0.05). The low frequency-high frequency 
ratio, an indicator of sympathetic nervous system activity, increased above rest at LBNP > -
40 mmHg in the men while it increased only at presyncope in the women (P<0.05). These 
data suggest that gender differences in orthostatic tolerance may be due, at least in part, to 
differences in the autonomic responses to this stressor. 
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INTRODUCTION 
The cardiovascular responses to orthostatic stress have been investigated extensively 
and are well documented [1,2,3]. In general, when significant blood volume is shifted to the 
lower body, venous retum, stroke volume (SV), and arterial pressure decrease while 
increases in heart rate (HR), cardiac contractility, and peripheral vasoconstriction occur to 
maintain arterial pressure [4,5,6]. Mild lower body negative pressure (LBNP) (<-20 mmHg) 
results in the unloading of cardiopulmonary baroreceptors through reduction in central 
venous and right atrial pressures. To a lesser extent, these low levels also unload arterial 
baroreceptors although higher levels of LBNP further unload arterial baroreceptors by 
reducing arterial pressure and aortic pulse pressure (PP). Cardiopulmonary baroreceptor 
unloading results in decreases in forearm blood flow while arterial baroreceptor unloading 
results in marked increases in splanchnic vasoconstriction [7,8,9]. 
Several studies have compared the cardiovascular responses to submaximal 
orthostatic stress between genders [4,5,6,10,11,12,13,14,29]. When compared with men at 
the same level of orthostatic stress, women have greater HR, forearm vasoconstriction and 
pelvic blood pooling while men have greater systemic vasoconstriction and greater lower 
limb blood pooling [4,5,6,13]. Moreover, at rest, women tend to have a higher HR [6], a 
lower systolic blood pressiu-e (SEP) [5], less peripheral vascular tone, and less skeletal 
muscle mass [15]. However, none of these resting differences has been shown to 
significantly affect the cardiovascular responses to LBNP [15,16,17]. 
Few studies have compared orthostatic tolerance between genders, but women are 
generally thought to possess a lower tolerance to orthostatic challenges [4,10,11,12]. 
However, this is not a universal finding since some studies reported no gender differences in 
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orthostatic tolerance [14], In ail these studies, the women were relatively shorter and lighter 
than men. Smaller body size is associated with smaller heart size, less heart muscle mass, 
and less blood volume [4,13,19,20]. Paradoxically, height is inversely related to orthostatic 
tolerance in men [18]. If this finding applies to both genders, gender differences may have 
been partly masked through the use of groups of subjects differing in body size as well as 
gender. 
Nevertheless, different mechanisms in blood pressure regulation may play an 
important role in orthostatic tolerance since women tend to have a lower baroreflex 
sensitivity [4,21,22], a lower sensitivity or density of peripheral adrenergic receptors [23,24], 
and a lower resting sympathetic activity based on spectral analysis of heart rate variability 
(HRV) [25]. Also, it has been hypothesized that women respond to orthostatic stress more 
by vagal withdrawal, while men respond with greater sympathetic stimulation [5,26]. 
Evaluating the autonomic nervous system is considered an essential step in studying 
blood pressure regulation. HRV is a unique indicator of cardiac autonomic flmction; it is 
capable of reflecting the interplay between autonomic factors that control the cardiovascular 
system [27]. As such, power spectral analysis of HRV provides a unique tool for study of the 
underlying patterns of HR which reflect the neural-cardiovascular regulatory system, and it is 
useful in determining the autonomic modulation of HR [28]. 
We have used this technique to show that, for a given level of submaximal orthostatic 
stress, men reacted with more sympathetic activity than women [29]. However, differences 
in submaximal responses may not reflect differences in orthostatic tolerance. Assessment of 
possible gender differences in the autonomic responses using orthostatic stress carried to 
presyncope is essential for understanding this topic. Consequently, the piupose of the 
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present study was to test the hypothesis that differences in autonomic control of blood 
pressure may contribute to differences in orthostatic tolerance between genders. To reduce 
die potential confounding influence of group differences in body size, we matched subjects 
for height and weight. 
METHODS 
Subjects 
Healthy college-age men (n=8) and women (n=7) volunteered to participate as 
subjects for this study. Table 1 lists the physical characteristics of subjects by gender. All 
subjects were verbally informed of the intent and procedures of the study with written 
consent, a medical history questionnaire, and a physical activity questionnaire [30] 
completed prior to data collection. Subjects were instructed to refrain from consimiing 
caffeine- and alcohol-containing products and from performing vigorous exercise 24 hours 
prior to the LBNP protocol. In the women, no effort was made to match LBNP testing with 
menstrual phase since it has been reported that the cardiovascular responses to LBNP are 
unaffected by this variable [26, 31]. All protocols and procedures were approved by the 
Human Subjects Review Committee of Iowa State University. 
Data collection 
Subjects were instrumented for the measurement of HR and blood pressure. HR was 
acquired beat-to-beat using a lead n electrode configuration (Model 1500B 
electrocardiograph, Hewlett-Packard, Andover, MA). Blood pressure was assessed every 
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minute using an automated sphygmomanometer (Dinamap 9300, Critikon, Tampa, FL) 
placed on the right arm. 
LBNP protocol 
Following instrumentation, the subject was placed supine in an LBNP chamber, 
sealed at the level of the iliac crest, and straddling a bicycle seat with the feet unsupported. 
After a 10 min control period at ambient barometric pressure (0 mmHg), 10 mmHg increases 
in negative pressure were imposed every 6 min until either completion of the test at -100 
mmHg or occurrence of presyncope symptoms. Presyncopal symptoms consist of a drop in 
SBP > 15 mmHg, progressive reduction in SEP to < 80 mmHg, a sudden decrease in HR, or 
any symptoms of light-headedness, nausea, sweating, dizziness, or tunnel vision. The subject 
was frequently reminded to avoid any leg muscle movement and to remain inactive. LBNP 
tolerance was quantified by both the LBNP tolerance index (LTI) [14] and the cumulative 
stress index (CSI) [32]. CSI is more commonly used as an index of comparison in LBNP 
test; however, it has curvilinear characteristics while LTI is linear and has a higher 
correlation with central venous pressure [14]. 
Assessment of heart rate variability 
The analog output of the electrocardiogram was digitized and stored in data files on a 
personal computer using an anti-aliasing filter and amplification unit (AT-MI016-L9, SCXI 
1000, and SCXI 1121, National instrumentation, Austin, TX). The data were processed to 
detect the R-R intervals using an algorithm based on the modified threshold method. The R-
R intervals were manually inspected for missing or ectopic beats, if found, they were 
replaced by interpolated beats. The HRV spectrum was calculated with Welch's averaged 
periodogram method [33] using the last 256 R-R intervals of the rest period (0 mmHg) and 
the last 256 intervals of each level of LBNP. 
The HRV spectral power associated with different frequency bands of response was 
calculated by integrating the amplitude of the spectrum over the desired frequency range. 
Total power (TP) for each subject was defined as the area under the HRV spectrum between 
tlie frequencies of 0.001 to 0.5 Hz. The low frequency (LF) component of the spectrum was 
between 0.04 - 0.15 Hz and the high frequency (HF) component was between 0.15 - 0.40 Hz 
[28]. Data were subsequently normalized [28, 34] to minimize the effect of reductions in 
total power on the interpretation of the changes in LF and HF that occur with LBNP. HF is 
indicative of the parasympathetic nervous system, or vagal, influence on HRV while the LF 
likely reflects both parasympathetic and sympathetic modulation of HRV, or sympatho vagal 
balance [35]. The LF/HF ratio therefore served as an indicator of sympathetic nervous 
system activity [34]. 
Statistical analyses 
Mean arterial pressure (MAP) was calculated as the sum of diastolic blood pressure 
(DBP) and 1/3 PP. For statistical analysis, the mean of 6 minutes of data for each LBNP 
level common to all subjects (i.e. < - 40 mmHg) and die averaged data of each subject at the 
final level of LBNP were determined. The data were evaluated using two-way repeated 
measures analysis of variance. Post hoc comparisons were made using the Student-Newman-
Keuls procediure. Gender differences in the subject characteristics, LBNP tolerance, and 
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resting cardiovascular variables were assessed using one-way analysis of variance. Statistical 
significance was accepted at P<0.05. Data have been expressed as mean ± SE. 
RESULTS 
A summary of the physical and baseline physiological characteristics for the subjects 
is presented in Table 1. Men were significantly heavier (P<0.05) and leaner than the women 
(P<0.005), but did not differ in body mass index and body surface area. At rest men had 
significantly higher systolic, lower diastolic, and larger pulse pressures (P<0.0001). MAP 
was slightly but significantly higher in the women (P<0.05). However, there were no 
significant differences in HR and HRV data between the groups. 
[INSERT TABLE 1 HERE] 
LBNP tolerance 
Women were significantly less tolerant to LBNP than men (CSI: 1246 ± 132 vs 2206 
± 334 mmHg.min*'; LTI: 353 ± 21 vs 474 ± 39 mmHg.min"'; P<0.05). Five out of 7 females 
failed to complete -60 mmHg LBNP while only 1 of the 8 males failed to complete -60 
mmHg. 
Cardiovascular responses to LBNP 
In both groups, HR increased significantly above rest at LBNP of -40 mmHg (Table 
2; P< 0.05); it increased 140 ± 6 % (+25 bpm) in women and 152 ± 13 % (+30 bpm) in men 
at presyncope. However, HR responses to LBNP were similar in both groups. 
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[INSERT TABLE 2 HERE] 
The blood pressure responses to graded LBNP are shown in Figure 1. MAP and SB? 
did not change significantly in the men. In women, MAP fell below rest at > -30 mmHg of 
LBNP (P<0.05). However, this decline was a maximum of only 6 mmHg at presyncope 
(P<0.001). SBP remained significantly lower in the women throughout LBNP (P<0.01) and 
it fell below rest at > -30 mmHg of LBNP (P<0.05). 
[INSERT FIGURE 1 HERE] 
DBP was significantly higher in women compared to men at < -40 mmHg of LBNP 
(P<0.05) and it changed significantly with LBNP (P<0.0001). In women, DBP fell 
significantly below rest at > -30 mmHg of LBNP; in men, it changed significantly only at the 
presyncope level of LBNP (P<0.05). At presyncope, DBP decreased in women but increased 
in men (-5.8 ± 1.9 vs 5.5 ± 1.9 mmHg, P<0.001). PP remained higher in the men throughout 
LBNP (P<0.01). It did not change with LBNP in women, but it fell below rest at the final 
level of LBNP in the men (-12,6 ± 6.2 mmHg, P=0.08). 
While significant gender differences were seen in SBP, DBP, and PP at submaximal 
levels of LBNP, there were no significant differences in these parameters at presyncope. 
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Autonomic responses to LBNP 
Autonomic modulation of HRV, calculated from the data in Table 2, changed 
significantly with LBNP in both groups (P<0.0001). The total power changed significantly 
with LBNP in both groups (P<0.0001). Gender differences in total power are seen at -30 and 
-40 mmHg of LBNP (P<0.05). In both groups, the indicator of parasympathetic activity, 
normalized fIF, increased above rest at -10 mmHg and then decreased. However, in males, 
HF decreased significantly at > -30 mmHg of LBNP while it decreased significantly only at 
presyncope in women (P<0.05). HF tended to be lower in the men than the women at -30 
mmHg (P= 0.07) and was so at - 40 mmHg (P<0.05). The LF response paralleled HF but 
was directionally opposite due to normalization [28]. The indicator of sympathetic activity, 
the LF/HF ratio, changed significantly with LBNP in both groups (P<0.001). This ratio 
increased above rest at > -40 mmHg of LBNP in the male's (P<0.05) while it changed only at 
presyncope in women; consequently, gender differences were seen at -30 mmHg (P= 0.08) 
and -40 mmHg of LBNP (P<0.05). 
DISCUSSION 
The purpose of this experiment was to determine whether there were gender 
differences in the autonomic responses to the orthostatic stress of LBNP. A unique aspect of 
this study is that subjects wath similar age, height, body surface area and physical activity 
were recruited to eliminate the size differences between genders. The major findings of this 
study are that women have lower tolerance to graded LBNP than men and also have different 
autonomic and blood pressure response to submaximal orthostatic stress. However, similar 
responses were observed at presyncope in both groups. 
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Women appear to become presyncopal at a lower level of LBNP than men; in 
women, CSI was 44 % less than that for men. This result is consistent with findings from 
previous investigations where women had significantly lower orthostatic tolerance 
[4,6,10,11,12]. It has been postulated that this lower tolerance in women was mainly due to a 
higher baseline HR, less HR response to carotid baroreceptor stimulation, and lower resting 
SBP [4,6,10,12,26]. 
In our study, unlike other studies [6,12,13,26], there were no significant gender 
differences in HR either at baseline or throughout the LBNP protocol. Therefore, our results 
are at odds with other findings suggesting that higher HR in women account for gender 
differences in orthostatic stress [26]. Our finding may be due to the similar body size and 
activity levels in both genders in our study. In most other studies comparing gender 
differences to orthostatic stress, the women were physically shorter and lighter [4,6,12] likely 
resulting in heart size differences between genders [19,20]. Therefore, we suggest that HR 
differences in the previous studies might be due to the body size differences between the 
gender groups. Also, our study suggests that a higher HR at baseline and lower HR 
responses do not appear to be major contributors to less orthostatic tolerance in women, since 
the women in our study were less tolerant than the men in spite of similar HR responses to 
LBNP. 
When exposed to graded submaximal LBNP, the subjects in both groups experienced 
reductions in HF but increases in LF and LF/HF ratio. These results reiterate the findings of 
others [36] that increases in the HRV indicator of sympathetic activity are seen with LBNP. 
We extend these findings by showing that gender differences in this response exist. HR 
significantly increased above rest at > -40 mmHg in both groups. The HRV results suggest 
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that this HR changed more due to sympathetic activity in men. However, the HR response in 
the women was more likely by withdrawal of parasympathetic. This finding supports the 
suggestion of Frey and Hoffler [5] that, under orthostatic stress, increases in HR in women 
are mainly due to vagal withdrawal while more sympathetic stimulation is seen with an 
increased HR in men. 
Although there were gender differences in the autonomic responses at -30 (P=0.08) 
and -40 mmHg, both genders had similar autonomic activities at presyncope. However, at 
presyncope, women tended to have lower sympathetic nervous activity based on LF/HF ratio 
despite similar HR responses to LBNP. This result is consistent with the observation by 
Convertino [4] that HR in women did not differ from men at presyncope even though women 
had a significantly lower level of plasma norepinephrine than men. 
A novel finding of this study is that the women did not experience increases in 
sympathetic activity as rapidly as men. Sympathetic activity in women increased abruptly at 
presyncope, while, in men, it progressively increased at > -30 mmHg of LBNP. Likewise, 
parasympathetic activity declined more markedly at presyncope in the women than the men. 
This was consistent with the findings of Convertino [4]. 
The men were better able to maintain blood pressure under orthostatic stress than the 
women. Blood pressure did not change significantly with LBNP in men while it declined 
with each stage of LBNP in the women, becoming significantly lower than rest at > -30 
mmHg. At rest, women showed slightly but significantly lower SBP, but higher DBP 
resulting in lower PP compared to men. These resting differences in DBP, SBP, and PP in 
both genders was maintained through -40 mmHg. However, DBP increased above rest at 
presyncope in men suggesting a greater vasoconstrictor response. It decreased in women 
77 
resulting in a tendency toward reductions in MAP at presyncope. These results are similar to 
previous studies that tended to find an elevation in DBP in men and a decrease in DBF in 
women [6]. LBNP-induced declines in SB? were observed in both genders [4,6,13]. 
Arterial blood pressure is maintained by peripheral vasoconstriction, compensatory 
change in HR, or a combination of these two factors during LBNP [1]. In our study, during 
submaximal LBNP, men maintained blood pressure by an increased sympathetic activity 
which increased HR and probably caused increased peripheral vasoconstriction. Blood 
pressure decreased in the women due to the limited effect of parasympathetic withdrawal on 
HR. At syncope, both genders employed sympathetic activity and increases in HR; however, 
men showed stronger sympathetic activity than women which is similar to that seen by others 
[4]. 
With this study, we confirmed other studies indicating that women possessed less 
orthostatic tolerance than men. Our findings suggest that gender differences in HR seen by 
other researchers may be due to a group difference in body size and a higher baseline HR is 
not a major factor in the lower LBNP tolerance in women. The cardiovascular responses and 
autonomic activities at presyncope did not differ between genders. However, the HRV data 
suggest that progressive increases in sympathetic activity were seen in men throughout 
LBNP, while women experienced greater parasympathetic withdrawal at submaximal LBNP 
but statistically similar sympathetic activity at presyncope. We therefore conclude that 
differing tolerance to orthostatic stress between genders may be due, at least in part, to 
differences in the autonomic modulation of the cardiovascular system to maintain blood 
pressure. 
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Table 1. Physical characteristics and baseline physiological data of the subjects. 
Female Male 
Mean SE Mean SE 
# Subjects 7 8 
Age(yr) 22.3 0.5 22.6 0.8 
Height(cm) 171.6 4.0 174.9 2.5 
Weight(kg) 67.4 3.8 77.8 3.2 
Body fat(%) 20.9 1.9 12.4 1.4 t 
Body surface area(m") 1.79 0.1 1.93 0.1 
Body mass index(kg«m'^) 22.8 1.1 25.4 0.5 + + 
Heart rate(beats*min'') 62.7 1.0 61.6 1.3 
Systolic pressure(niniHg) 110.5 1.2 121.6 1.2 % 
Diastolic pressure(mmHg) 67.2 1.1 58.0 0.8 * 
Mean arterial pressure(TnmHg) 81.6 1.0 79.2 0.6 + 
Pulse pressure(nimHg) 43.3 1.3 63.5 1.6 * 
Low frequency(units) 54.9 6.0 62.2 1.7 
High frequency (units) 40.8 6.3 33.7 2.2 
LF/HF ratio 1.7 0.4 1.9 0.2 
* P<0.0001 
t P<0.005 
t P<0.05 
Table 2. Heart rate and autonomic nervous activities at rest and in response to lower body negative pressure. 
Lower Body Negative Pressure (mmHg) 
Variable 0 -10 -20 -30 -40 End point 
Heart Rate 
Females 
Males 
Low Frequency (n.u.) 
Females 
Males 
High Frequency (n.u.) 
Females 
Males 
LF/HF ratio 
Females 
Males 
62.7 + 1.0 61.0 + 1.1 » 61.9 + 1.1 64.6 + 1.4 68.5 + 1.7 *t 87.5 + 4.7 *t 
61.6 + 1.3 60.9 + 1.4 62.2 + 1.4 63.5 + 1.4 68.2 + 1.4 *t 91.8 + 4.3 *t 
54.9 + 6.0 43.1 + 6.5 50.2 + 3.2 50.9 + 6.1 55.0 + 6.4$ 76.8 + 4.8 *t 
62.2 + 1.7 47.2 + 4.1 * 55.8 + 4.6 65.2 + 5.01 75.4 ^3.8*1 81.9 + 3.3 *t 
40.8 + 6.3 53.8 + 6.4 47.2 + 3.2 45.3 + 5.9 41.8 + 6.3 t 20.3 + 4.4 *t 
33.7 + 2.2 47.0 + 2.9* 39.9 + 4.9 31.0 + 4.3 f 22.1+ 3.6 *t 16.2 + 3.0 *t 
1.7 + 0.4 1.0 + 0.3* 1.1+0.2 1.4 + 0.3 1.8 + 0.6$ 4.9+1.0*t 
1.9 + 0.2 1.1+0.2* 1.6 + 0.3 2.6 + 0.61 4.3 + 0.8 *t 7.8 + 2.5* 
* P<0.05 vs rest; t P<0.05 vs previous stage; J P<0.05 between genders. 
Figure 1. Blood pressure responses to graded maximal lower body negative pressure in 8 
males and 7 females. Dotted line ( ) indicate females and solid lines 
( ) males. Data have been expressed as mean ^ SEM. * P<0.05 vs 
rest for females;. ** P<0.05 vs rest for males; J P<0.05 females vs males. 
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V. ANALYSIS OF THE HEART RATE VARIABH^ITY USING 
WAVELET ANALYSIS MEHTOD 
A paper to be submitted to the Journal of Biomedical Engineering 
Kichang Lee, Jaein Lim, Alison B. Flatau, and Warren D. Franke 
ABSTRACT 
It is hypothesized that wavelet analysis could overcome limitations underlying 
application of spectral analysis for study of heart rate variability (HRV). The spectral 
analysis method produces valuable information such as hidden periodicity of the signal in the 
frequency domain. However, spectral analysis proves only a one-dimensional, frequency, 
description of the signal resulting in losing temporal information. Additionally, the 
stationarity of the signal is an important assumption underlying appropriate use of spectral 
analysis to evaluate a given signal and this is generally a poor assumption when dealing with 
biological signals. Wavelet analysis techniques were applied to the HRV signals to 
overcome these limitations of spectral analysis. 
Use of wavelet transform and spectral analysis techniques for analysis of autonomic 
nervous activity using HRV data were compared by studying heart rate intervals from 12 
subjects who underwent lower body negative pressure (LBNP) to -60 mmHg with 
increments of 10 mmHg in negative pressure every 6 minute. This study suggests that 
wavelet analysis of heart rate yields similar autonomic responses to LBNP as those produced 
by applying spectral analysis methods to a subset of 256 relatively stationary beat-to-beat 
intervals. However, unlike spectral analysis in which only the stationary portion of the beat-
to-beat interval data should be considered to study HRV, wavelet analysis provides 
information on the entire signal including transient data. Also, wavelet analysis provides a 
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two-dimensional time and frequency description of a signal, consequently revealing dynamic 
changes of autonomic nervous systems responses to LBNP suggesting wavelet analysis is 
offers distinct advantages over spectral analysis as a tool for studying heart rate fluctuations. 
INTRODUCTION 
Heart rate variability (HRV) is becoming widely used to assess autonomic neural 
control of the heart. For clinical studies, HRV is used to determine the effects of pathology 
on changes in modulation of the autonomic nervous system (4,12,13,24). It can also be used 
to investigate autonomic responses to orthostatic stress induced by tilt table or lower body 
negative pressure (LBNP) (7,10,14,16,18). 
HRV has become popular mainly because it is a non-invasive and a relatively easy 
method for studying autonomic control of the heart. However, the interpretation of the 
significance of HRV responses is rather difficult; part of this difficulty is due to the use of 
inconsistent HRV data sizes and interpretation techniques (24). 
HRV can be analyzed by both time domain and frequency domain methods. Time 
domain analysis is the simplest approach in which the statistical parameters of beat-to-beat 
(RR) intervals are studied. It has proved useful as a clinical tool (24). Frequency domain 
study entails the assessment of frequency components and amplitude of HRV by spectral 
analysis of the RR intervals based on Fourier transformation, and is the most common 
technique used in research (2,3,7,10,16,22). 
Fourier transforms and spectral analysis is widely used for the analysis of signals to 
provide a complete description of a stationary signal in the frequency domain. However, 
spectral analysis has limitations when the signal to be analyzed is non-stationary, as are the 
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HRV responses to LBNP or tilt table testing. This dilemma can be partly resolved by 
excluding transient data introduced by sudden changes in LBNP level and by dividing non-
stationary signals into blocks of short HRV signal segments that satisfy stationarity 
conditions (having statistical properties such as mean, variance, and probability density 
functions that do not vary with time). However, this short segment analysis may cause poor 
frequency resolution and may introduce loss of important physiologic information by 
excluding transient and/or transitional portions of the signal. 
Spectral analysis of HRV has been shown to produce valuable information about the 
autonomic modulation of the heart in the frequency domain, but consequently introduces a 
loss of HRV temporal information. Wavelet analysis techniques simultaneously provide 
information on signals in both the time and frequency domains and are suitable for transient 
or non-stationary signals as well as stationary signals (5) and as such can be used to 
circumvent limitations associated with spectral analysis. 
Relatively few studies have explored the feasibility of applying wavelet analysis 
techniques to HRV (8,25,26), with even fewer studies comparing wavelet analysis of HRV 
data to the spectral analysis (15). Furthermore, none of these studies have assessed wavelet 
analysis on the HRV responses to LBNP, a common tool for increasing heart rate (HR) by 
graded central hypovolemia and for provoking marked changes in the autonomic control of 
HR. 
In the literature, it remains uncertain whether wavelet analysis is more appropriate 
than spectral analysis in evaluating HRV. The main purpose of the present study was to test 
the hypothesis that wavelet analysis techniques are better tools than spectral analysis methods 
for assessment of HRV data at rest and under LBNP conditions. 
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METHODS 
Subjects 
Healthy college-age men (n = 12) volunteered to participate as subjects in this study. 
All subjects were verbally informed of the intent and procedures of the study with written 
consent obtained prior to data collection. All protocols and procedures were approved by the 
Human Subjects Review Committee of Iowa State University. Subjects were instructed to 
refrain from consuming caffeine and alcohol containing products and from performing 
vigorous exercise 24 hours prior to each maximal LBNP test. 
LBNP testing protocol 
Following instrumentation, each subject was placed supine in the LBNP chamber, 
sealed at the level of the iliac crest, and supported with an adjustable bicycle saddle for 
stabilization. After a 15 minute resting control period at ambient barometric pressure (0 
mmHg), negative pressure was imposed in 10 mmHg increments every 6 minutes until either 
completion of the test at -60 mmHg or the onset of signs and symptoms of presyncope. 
Indicators of impending presyncope included a drop in systolic blood pressiure (>25 
mmHg-min''), progressive reduction in systolic blood presstu-e (to <80 mmHg), a sudden 
decrease in HR (>15 beats-min"') or subject symptoms such as light-headedness, nausea, 
sweating, dizziness, or gray-out (blurred vision). Throughout testing, subjects breathed at a 
frequency of 0.2 Hz (12 breaths-min"', 2.5 seconds expiration, 2.5 seconds inspiration) using 
visual cues to maintain the desired rate. Subjects were frequently instructed to avoid any leg 
muscle movement and to remain quiescent during the LBNP trials. 
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Measurements 
Subjects were instrumented for the measurement of HR and blood pressure. HR was 
acquired beat-to-beat using a lead U electrode configuration (Model 1500B 
electrocardiograph, Hewlett-Packard, Andover, MA). Blood pressure was assessed beat-to-
beat using a Finapres (Ohmeda, Englewood, CO) placed on the right long finger. The analog 
outputs of the electrocardiogram and Finapres were digitized and stored in data files on a 
personal computer using an anti-aliasing filter and amplification unit with a 1000 Hz 
sampling rate (AT-MI016-L9, SCXI 1000, and SCXI1121, National Instrumentation, 
Austin, TX). 
The electrocardiograms were further processed to detect the R-R intervals using an 
algorithm based on the modified threshold method. The R-R intervals were manually 
inspected for ectopic and/or missing beats (beats that were buried in signal noise). No 
ectopic beats were found. Noise was filtered firom signals to allow proper identification of R-
R intervals where beats appeared to be missing. The HRV spectrum was calculated with 
Welch's averaged periodogram method using a stationary 256 R-R interval for the rest period 
and each level of LBNP (21,23). Due to the importance of stationarity of data for spectral 
analysis, the first minute of HRV data of each level of LBNP was excluded firom the analyses 
and the Dickey-Fuller test was performed to test stationarity of the remaining HRV data (19). 
In the application of wavelet analysis technique in this study, the R-R intervals were used 
with a "Daubechies 5" wavelet with 4 levels of decompositions for data sets of between 6 
and 10 minutes and with 5 levels of decompositions for data sets of greater than 10 minutes. 
The wavelet coefficient was calculated and converted into an equivalent frequency value for 
presentation in the time-frequency domain described in Figure 1. 
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Heart rate variability 
HR is mainly modulated by the net of autonomic nervous system activities. The 
HRV is a unique indicator of cardiac autonomic function reflecting autonomic system 
influence on the heart. The traditional approaches for assessment of HRV is by spectral 
analysis techniques which are the most widely used tools in study of the underlying HR 
pattems and for determining the balance of sympathetic nervous activity, which accelerates 
HR, and parasympathetic nervous activity, which slows HR (20,24). 
The spectrum of HRV associated with different frequency bands of response was 
calculated by integrating the amplitude of the spectrum over the desired frequency range. 
Total power for each subject was defined as the area under the HRV spectrum between the 
frequencies of 0.001 to 0.5 Hz. The low frequency (LF) component of the spectrum was 
determined from the area under the spectrum at frequencies between 0.04 - 0.15 Hz and the 
high frequency (HF) component was from the area under the spectrum between 0.15 - 0.40 
Hz (24). Data were subsequently normalized (14, 24) to minimize the effect of reductions in 
total power on the interpretation of the changes in LF and HF that occur with LBNP. HF is 
indicative of the relative level of parasympathetic nervous system, or vagal, influence on 
HRV while the LF likely reflects both parasympathetic and sympathetic modulation of HRV 
(17, 24). While the specific values for LF and HF can vary greatly, it is the LF/HF ratio that 
serves as an indicator of sympathetic nervous system activity (14). 
Spectral analysis of HR V 
Spectral analysis decomposes and expresses a signal as a siun of sinusoidal frequency 
components that determine the distribution of the signal response over a range of frequency. 
Spectral analysis may provide "hidden information" in the signal such as periodicity. 
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The power spectrum density (PSD) of signal X[n] is defined as: 
S  ( o ) )  =  3[/?(r)] = J] [r] exTpi-Jcor) 
r--cc 
where, /?[r] = £ ( ^ X [ n ] X [ n  + r]), 3[*] indicates Fourier transform, c o  means frequency, t is 
a time lag, and E(*) represents the expectation operator (6). 
Since, theoretically, an infinite number of autocorrelation function values (i?[r]) is 
required to compute PSD, researchers have derived the various mathematical algorithms to 
estimate the PSD that are most appropriate for analysis of stationary data (23) and a 
periodogram is the one of the most popular methods to estimate PSD: 
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The stationarity of the signal is the important underlying assumption of the above 
equations. However, most signals in physiologic-related research areas, such as 24 hour HR 
monitoring of resting subjects, responses to LBNP, or responses to tilt-table testing, are not 
stationary. An example of HRV responses of a normal subject to LBNP (fi-om 0 to -60 
mmHg) that illustrating a lack of stationarity is shown in Figure 2. 
Wavelet analysis 
The wavelet is mathematical tool for representing signal by a set of basis functions 
and a l l  b a s i s  f i m c t i o n s  c a n  b e  g e n e r a t e d  b y  a  s i n g l e  s c a l i n g  f u n c t i o n ,  ( p { x ) ,  o r  w a v e l e t ,  \ f / { x ) ,  
by scaling and translation (Bumis et al., 1998): 
= 2 ' ' ^ ( p { 2 ' x - k )  
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where j and k are integers. 
A set of basis functions is generated from the basic scaling function by scaling and 
translation: 
k 
H x )  =  Y ^ K k ) ( p { 2 x - k )  
k 
where g ( k ) = ( - l Y  h Q .  - it) is a scaling coefficient and h(k) is the wavelet coefficient. 
The wavelet transform produces coefficients representing the correlation between the 
wavelet and small sections of the input signal, as a function of scale and position (shift). The 
wavelet coefficients of a signal f{x) is: 
Kj, ' f/w dx 
—CO 
a,b 
The wavelet analysis is an iterative decomposition process with successive slicing 
approximations into the desired lower resolution components. At each level, the detail (high 
frequency) is stored but the approximate (low frequency) is decomposed continuously for the 
next level. Wavelet packet decomposes successively both approximation and detail into the 
next level approximations and details. Consider an Z-level decomposition, which can be 
written as (5): 
f i x )  =  { x ) + J ^ d j , i ; / j , { x )  
k k 
Coefficients Oy ^ and djj^ are 
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where, 0 < j  ^ L .  
Similarly, a recursive algorithm for synthesizing flmction can be derived based on its wavelet 
coefBcients dj j^, and aj ^ 
-  2 m )  +  Y , d j , „ g { k  -  2 m )  
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The graphical description of wavelet decomposition is presented in Figure 1. 
Figure 3 and 4 present a simple comparison of PSD and wavelet analysis in the 
analysis of two signals that consist of the same three different frequency components. The 
signal in Figure 3 is the simi of the three frequencies when simultaneously generated for the 
duration of the 3000 data points, while the signal in Figure 4 is formed from the sequential 
generation of the three frequencies for 1000 data points each. The spectra of the two signals 
(the middle plot) are similar, thereby illustrating an inadequacy of PSD methods for use in 
assessing the time-dependent information in the signal. The time dependent information is 
evident in the wavelet result (the lower plot), thereby illustrating an advantage that can be 
realized by employing wavelet analysis methods. 
RESULTS AND DISCUSSION 
A typical resting HRV and its spectrum are presented in Figure 5 a and b. 
respectively. In the spectnmi, three distinct peaks exist; peaks in the very low frequency 
range (< 0.04 Hz), the low frequency range (0.04 - 0.15 Hz), and the high frequency range 
(0.15 - 0.4 Hz). The main peak in the high frequency component was observed around 0.2 
Hz which is the respiration rhythm (12 breathings per minute) confirming that the high 
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frequency component is closely related to respiration rhythm (17). Figxure 5c consists of 
three wavelet plots indicating the relative amplitude of wavelet response at frequencies in the 
low frequency range (upper plot), the high frequency range (middle plot) and of the LF/HF 
ratio (lower plot). Frequency range information was obtained by converting from the 
Daubechies 5 wavelet scale to frequency domain. The time domain resolution is tied to that 
of the wavelet used. Note that in lieu of the single valued information available from the area 
under the curves in the spectral plot (figure 5b), the wavelet approach provides information 
on the relative physiologic responses as they vary during the course of the full 10 minute test 
period. A particularly interesting result demonstrated in the lowest plot is that with a 
Daubechies 5 wavelet and 4 levels of decomposition the LF/HF value obtain from the 
spectral analysis method (shown by the dotted line) correlates very closely to the mean 
LF/HF wavelet value. 
EIR intervals, the standard deviation of RR intervals, and parasympathetic nervous 
activities decreased with increment of LBNP. Figures 6a and 6b respectively show an 
example of the HRV signal and its PSD spectrum obtained at a level of LBNP of-50 mmHg, 
which compared favorably with similar results from the open literature (10). By comparing 
Figure 5b and 6b, it is quite evident that a reduction in the HF response occurs, which is 
indicative of autonomic activity at this level in which sympathetic activity is dominant while 
parasympathetic activity is depressed. This visual comparison can be made equally well by 
examining and comparing the HF wavelet plots in Figures 5c and 6c. Note also that LF/HF 
ratio values obtained by the wavelet methods are greater in Figure 6 than in Figiure 5, as 
expected given the relative decrease in the HF values. The single valued PSD LF/HF ratio at 
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rest, as in the Figtire 5 LF/HF wavelet plot, is shoAvn in Figure 6 to further illustrate the 
increase in LF/HF ratio with decreased LBNP. 
Figure 7 shows LF/HF ratio results obtained by both wavelet and spectral analyses 
techniques for each of the 12 study subjects' entire test protocol as LBNP ranged from 0 to -
60 mmHg. To facilitate visualization of variations in LF/HF ratio amplitude with time, both 
the wavelet and spectral results in Figure 7 have been normalize to a magnitude of 1.0. Note 
that the spectral analysis results are discontinuous, and provide only a single value that 
reflects frequency averaged information from only a somewhat arbitrarily identified 
stationary portion of the total test protocol data. (As will be shown in Figure 8, within each 
level of LBNP different subsets of data that satisfy stationary conditions can be identified.) 
Wavelet analysis provides significantly more detailed information on change in LF/HF 
components with time and LBNP, while spectral analysis yields only a single constant per 
LBNP level. 
Noting that in general a balance between the parasympathetic and sympathetic vagal 
activities exists at rest, dashed and dotted lines have been added to the plots in Figure 7. In 
the wavelet plots a dotted line is use to indicate the LF/HF ratio values corresponding to this 
balance based on the mean LF/HF value obtained for each subject from their rest data (the 
first 10 minutes of the test protocol). The dashed lines in each of the PSD plots represent the 
true PSD LF/HF = 1.0 value and as is shown, is typical of resting data as calculated by PSD 
methods for each subject. 
It is worth noting that the value of the wavelet LF/HF ratios obtained will depend on 
the wavelet that is used and on the decomposition level used in processing the results. 
Further work is needed to standardize the wavelet and decomposition level suitable for 
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obtaining meaningful LF/HF values for correspondence to sympathovagal balance as is 
suggested by the PSD LF/HF resting value of 1.0. The data presented in Figtire 7 were based 
on a Daubechies 5 wavelet and 5 levels of decomposition. The wavelet LF/HF ratios in all 
cases were of smaller values than the spectral LF/HF results, and that only at the most 
negative LBNP levels did they tend to exceed a ratio value of 1.0. Thus, the wavelet LF/HF 
= 1.0 value generally will not convey the same information as PSD LF/HF ratio = 1.0 value 
which is generally used to explain the sympathovagal balance. However, it is hypothesized 
that the dotted line in the wavelet plots of Figure 7, which reflect the mean wavelet LF/HF 
ratio values at rest are a reasonable indicator of sympathovagal balance. 
Another concern associated with the application of spectral analysis methods is the 
selection of stationary data subset to be used at a given LBNP level. In general, Fourier 
analysis of the same number of HRV data points (i.e., 2^ = 256) throughout the test protocol 
is recommended to provide same frequency resolution. However, arbitrary factors used in 
the selection of which HRV data points are analyzed can lead to biased results. Figure 8 
shows three different spectra with 256 HRV data points but different intervals (1 second, 1.5 
minute, and 3 minute afler the start of - 50 mmHg of LBNP) taken from the signal shown in 
Figure 6. Even though the first two spectra exhibit slightly different autonomic activity 
responses, they have the similar trends in autonomic responses to LBNP with the sympathetic 
activity dominant. However, the third spectrum is significantly different from the other two, 
indicating that sympathetic activity is dominant at this stage but about 46 % less-so than the 
other results suggest. This result suggests that spectrum analysis is highly dependent on the 
data points analyzed. This means that spectral analysis method can produce the biased 
results that depend on the data selected to be analyzed. To avoid the biased result. 
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researchers need to exercise caution in identifying a stationary portion of HRV data so as to 
yield reliable results. 
The issues responsible for this disturbing result are not only confirmed by wavelet 
analysis, but arguably a distinct advantage of wavelet analysis over spectral methods is that it 
provides a look at the details of these non-stationary physiologic responses. Figure 6 (c) 
shows time and frequency description of autonomic nervous control of HR at a high level of 
LBNP analyzed by wavelet transform. Sympathetic activity is dominant in the first 3 minute; 
thereafter this activity decreases. This wavelet result explains why the first two spectral 
results indicate higher sympathetic activities than the third one. 
Based on this limited wavelet data, it is premature to make claims as to whether or 
not wavelet results acmally provide better resolution for interpretation of LF/HF ratio 
information as to dominance of parasympathetic versus sympathetic activity. Wavelet 
analysis provides significantly more detailed information on change in LF/HF frequency 
components over time, while spectral analysis yields only a single constant per LBNP level. 
In summary, spectral analysis of HRV provides valuable information on the 
autonomic control of the heart in the frequency domain. However, researchers frequently 
exclude transient data of the HRV signal and analyze remain portion of data to study HRV 
responses to LBNP. It is hypothesized that wavelet analysis may solve some of the problems 
associated with limits in the applicability of spectral analysis. Wavelet analysis in this study 
proved to adequately assess the state of sympathetic activity (LF/HF). It also showed that 
wavelet analysis is a useful tool to study HRV by showing time and frequency descriptions 
simultaneously. Therefore, we suggest that wavelet analysis is a useful complement to 
spectral analysis for use in assessing HRV data under LBNP. 
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Since this is the first study of the application of wavelet transform on HRV response 
to LBNP, further exploration of this method on HRV is necessary to assess its possible utility 
in research and clinical fields. 
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HGURE LEGENDS 
Figure 1. Wavelet packet decomposition with two-scale structure and complete coverage of 
the output on the frequency axis. 
Figure 2. An example of HRV responses to the entire LENP protocol (0 to - 60 nunHg of 
LBNP). 
Figure 3. The simulated time domain signal I (sum of 3 frequency component signals), 
frequency domain spectrum, and time-frequency representation of wavelet 
analysis. 
Figure 4. The simulated time domain signal 2 (cascade connection of 3 frequency 
component signals), frequency domain spectrum, and time-frequency 
representation of wavelet analysis. 
Figure 5. a) HRV data at rest, b) Spectral analysis of HRV data at rest, with dashed lines 
used to partition regions of the spectra that are summed to identify net low 
frequency (LF) and high frequency (HF) content of the spectral response, 
c) Changes in HRV frequency components and LF/HF ratio at rest (0 mmHg 
LBNP). The solid and dashed lines respectively indicate magnitude of wavelet 
and PSD low frequency to high frequency response ratios. 
Figure 6. a) Six minutes ofHRV data at-50 mmHg of LBNP. b) Spectral analysis of HRV 
data at - 50 mmHg of LBNP. c) Changes in LF, HF, and LF/HF ratio based on 
wavelet analysis of the HRV data at -50 mmHg. 
Figure 7. Changes in LF/HF ratio (normalized) estimated by wavelet analysis (left side) and 
spectral analysis (right side) of study subjects 1-3 entire HRV responses to LBNP 
(from 0 to - 60 mmHg of LBNP); dashed line ( ) represents LF/HF ratio = 1 in 
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PSD and dotted line (• • • •) represents LF/HF ratio mean value of sympathovagal 
balance at resting. 
Figure 7. Continued, results from study subjects 4-6. 
Figure 7. Continued, results from study subjects 7-9. 
Figure 7. Continued, results from study subjects 10 - 12. 
Figure 8. Spectra of Figure 16 HRV data using different data subsets: 
a. 256 data point (2.4 minutes) starting at 1 second. 
b. 256 data point (2.2 minutes) starting at 1.5 minute. 
c. 256 data point (2.3 minutes) starting at 3 minute. 
H, 
H, 
Ho 
Ho 7 
! 
H, 
Ho 
H, 
Ho 
H, 
Ho 
H, 
Ho 
H, 
Ho 
V 
•••> 
-r- fs/2 
7^  f s /16  
6^ f s /16  
5^ f s /16  
4^ f s /16  
3^ f s /16  
2^ f s /16  
1  ^  f s /16  
0 
frequency axis (Hz) 
Figure 1. Wavelet packet decomposition with three-scale structure and complete coverage of the output on the frequency axis. 
o 
106 
l . l  
> 
& 
0.4. 
0 500 1000 1500 2000 2500 3000 3500 4000 
Number of heart rate interval 
Figure 2. An example of HRV responses to the entire LBNP protocol (0 to - 60 mmHg of 
LBNP). 
107 
1000 1500 2000 
Number of data points 
2500 3000 
« 0.8-
a 
« 0.6-
O 
S 0 .4-
3 
S 0. 2 -Q. W 
0 -
0 10 20 30 40 50 60 70 80 90 100 
Frequency (Ife) 
350-
300. 
250: 
>. 200-U 
c u 3 
« 150 L Cb 
100-
X I I I I I I I  l i B H i i i  1 1 1 1 1 1  i n a r a i i  I I I I I I  c i n H i i f i  1 1 1 1 1 I I  
50-
I ri H i t iffA'flliS-'l I 
1000 1500 2000 2500 3000 
Number of data points of signal 1 
Figiire 3. The simulated signal 1 (sum of 3 frequency component signals), spectrum, and 
time-frequency representation of wavelet analysis. 
108 
J I 1 . < .. ):i ii liin )! iii JHHIM:! iiiiiniiiiiI!!;'iiwiiiiiiii'iiiinihi'!';;iiimi 
0 500 1000 1500 2000 2500 3000 
Number of data points 
d 10 20 30 40~ 50 60 80 90 ToO 
Frequency (Jfe) 
•3  0 -8 '  
M 0.6 -Cm 
o 
E 0 .4-
a 0. 2 -
a t/i 
350-
300-
250 L 
200 U 
c ii 3 
S" 150 
100-
50-
O i  
0 500 1000 1500 2000 2500 3000 
Number of data points of signal 2 
Figxu-e 4. The simulated signal 2 (cascade connection of 3 frequency component signals), 
spectrum, and time-frequency representation of wavelet analysis. 
109 
1.05 
a 0.85 
0.8-
0.75-
l ; 
i i i  
I i • 
!i. l  
i! J" 
0.7 
0 12 3 4 5 6 
Time (min) 
0.05 
Frequency (Hz) 
10 
0.04 -
< 0.02 H 
/I MU 
Figure 5. a) HRV data at rest, b) Spectral analysis of HRV data at rest, with dashed lines 
used to partition regions of the spectra. 
110 
Figure 5. c) Changes in HRV frequency components and LF/HF ratio at rest (0 mmHg 
LBNP). The solid and dashed lines respectively indicate magnitude of wavelet 
and PSD low frequency to high frequency response ratios. 
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Figure 6 c) Changes in LF, HF, and LF/HF ratio based on wavelet analysis of the HRV 
data at - 50 mmHg. 
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Figure 7. Changes in LF/HF ratio (normalized) estimated by wavelet analysis (left side) and spectral analysis (right side) of each 
individual's entire HRV responses to LBNP (from 0 to -60 mmHg of LBNP); dashed line ( ) represents LF/HF ratio 
of 1 in PSD and dotted line (—) represents LF/HF ratio renormalized value of sympathovagal balance at resting. 
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VI. CONCLUSION 
In these studies, autonomic and cardiovascular responses and reproducibility of these 
responses to orthostatic stress induced by lower body negative pressure (LBNP) were 
assessed. Gender differences in these responses were evaluated to determine a possible 
mechanism for the lower orthostatic tolerance in women than men. Also, wavelet analysis 
techniques were compared to spectral method using heart rate variability signal under LBNP 
protocol to assess autonomic nervous system activity. 
Autonomic activity can be assessed by studying HRV which is capable of reflecting 
the interplay between autonomic factors that control the cardiovascular system. Spectral 
analysis of HRV provides a unique tool for study of the underlying patterns of the HR, and it 
is useful in determining the autonomic modulation of HR. However, an important 
assumption underlying proper application of spectral methods is stationarity of the signal 
being analyzed. For this reason, it is necessary to test the stationarity of the signal using a 
statistical method such as the Dickey-Fuller test before evaluation of the HRV signal. 
In summary, the major findings of these studies are that 1) LBNP tolerance in men is 
repeatable, 2) autonomic and cardiovascular responses to LBNP are reproducible, 3) women 
have lower tolerance to graded LBNP than men and also have different autonomic and blood 
pressure responses to submaximal orthostatic stress, and 4) wavelet transform may be 
superior to PSD in studying autonomic control of the heart. 
In the first study presented, a high correlation coefficient (0.87) was calculated 
between two repeated tests in men suggesting excellent reproducibility of LBNP tolerance. 
Autonomic and cardiovascular indices showed parallel increases in two repeated trials. At 
rest, subjects had a LF/HF ratio of less than 1 suggesting higher parasympathetic activity. 
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Heart rate variability (HRV) parameters in both time and frequency domain showed good 
reproducibility. The present study also proved that cardiovascular indices were highly 
reproducible in most LBNP stages. Therefore, autonomic and cardiovascular responses to 
LBNP testing were reproducible. 
In the second study, no gender difference in the heart rate response to the LBNP was 
observed. Gender differences in HR in previous studies may be due to physical differences 
between genders. Men had higher sympathetic activity, based on spectral analysis, than 
women and this activity increased heart rate in men, while increases in heart rate in women 
might be due to vagal withdrawal suggested by Frey and Hoffler (1988). The spectral 
analysis of HRV data suggests that sympathetic activity was increased progressively with 
increases in LBNP in men, while women experienced parasympathetic withdrawal at 
submaximal LBNP but similar sympathetic activity at syncope. 
The final study showed wavelet analysis to be a useful tool for assessing autonomic 
nervous system activity with distinct advantages over the more traditional spectral analysis 
methods. Wavelet analysis provided more information on sympathetic and parasympathetic 
nervous system activities with time localization by providing a simultaneous time and 
frequency description. For evaluation of HRV signals with the wavelet analysis method, the 
signal does not need to be stationary which is important underlying assumption for spectral 
analysis that precludes suitability of spectral methods for assessment of transient responses. 
Therefore, we conclude that use of the wavelet analysis method to assess HRV is a useful 
complement to more traditional spectral analysis methods. 
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